rfhg_2379.1

Basic information about the TSS

---

TSS ID: rfhg_2379.1 Species: human Chr: chr1		Start: 17439971 End: 17439992 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2132551,EH38E1323173)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AJ421269:247 GeneID: 55920 HGNC/MGI_ID: HGNC:30297 UniProt_ID: Nearer transcript ids and distances: AB040903:286 LF357184:-293 MA592761:-293 ENST00000375436.9:294 NM_018715.4:294 LF357183:-379 MA592760:-379 view more...

Gene_name: regulator of chromosome condensation 2 Gene_symbol: RCC2 Gene_synonyms: TD-60 Gene_source: HGNC:30297

TATA-Box annotation

---

Distance to TSS:	-304
Nearest PromoterID:	NM_018715
Entrez ID:	55920
Nearest Unigene:	Hs.380857
Nearest Refseq:	NM_018715
Nearest Ensembl:	ENSG00000179051
Gene Name:	regulator of chromosome condensation 2
Gene Alias:	TD-60
Gene Type:	protein-coding
CpG%:	0.047619
GC%:	0.500000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RCC2 p2@RCC2 p3@RCC2 p4@RCC2 p5@RCC2 p6@RCC2 p8@RCC2 p9@RCC2
Sample		p1@RCC2	p2@RCC2	p3@RCC2	p4@RCC2	p5@RCC2	p6@RCC2	p8@RCC2	p9@RCC2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	28.44	31.56	20.06	8.77	2.34	2.53	0.19	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	24.68	31.16	20.84	9.31	2.63	2.83	0.00	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	26.81	32.99	22.38	9.84	3.09	1.35	0.96	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	24.74	30.35	24.12	7.69	3.33	1.25	0.83	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	24.30	38.47	26.32	7.42	2.70	1.80	0.00	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	22.48	34.30	24.42	6.20	0.78	2.13	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	37.26	46.41	41.18	12.86	4.14	1.31	1.31	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	34.40	38.03	30.52	12.11	4.12	2.66	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	33.98	38.47	27.36	10.90	2.35	4.49	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	28.40	42.89	26.08	2.90	3.48	2.90	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	23.85	35.17	20.21	4.45	0.40	3.23	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	23.99	47.97	17.89	5.29	1.63	3.66	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	7.09	8.38	11.44	0.48	2.10	0.97	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	6.31	9.02	7.97	2.10	1.80	0.30	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	7.03	5.49	8.34	0.88	1.98	0.88	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	4.28	5.78	9.05	1.76	1.26	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	7.21	6.55	10.27	1.75	1.53	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	9.28	7.59	9.70	1.69	0.84	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	4.27	3.73	14.40	1.60	1.60	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	7.67	7.22	10.53	2.71	1.35	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	7.89	5.08	7.62	2.41	0.94	0.27	0.27	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	8.63	9.49	10.36	1.55	1.90	1.04	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.14	6.33	9.82	1.29	1.94	0.52	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.22	6.07	11.65	3.15	1.70	0.24	0.24	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	8.51	9.80	14.96	3.61	1.29	0.52	0.26	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.08	7.28	11.71	3.17	1.90	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.34	9.89	13.19	3.30	0.55	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	17.92	12.26	12.97	2.12	0.94	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.50	7.75	9.37	1.45	1.29	0.81	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.12	9.23	13.57	2.53	2.35	0.90	0.00	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	12.56	8.58	11.72	3.56	1.67	0.63	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.04	7.82	10.36	1.95	1.56	0.00	0.20	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.40	7.60	12.24	2.32	1.48	0.42	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.91	10.56	13.20	2.80	1.65	0.99	0.49	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	15.71	9.54	10.28	4.86	1.50	0.56	0.37	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	13.22	7.47	11.11	1.53	2.11	0.57	0.38	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	14.72	8.18	8.18	4.09	1.64	0.41	0.00	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	15.31	7.05	9.87	2.42	2.01	0.81	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	17.56	8.37	5.40	2.43	1.35	0.54	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	17.52	8.64	8.40	3.12	0.96	1.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	13.88	5.65	9.88	2.35	1.41	0.94	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	10.39	8.78	10.69	2.64	2.05	0.44	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.19	5.91	7.80	2.95	2.53	0.63	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	16.26	5.94	8.74	4.20	1.75	0.52	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	17.67	7.43	9.44	2.81	2.61	0.60	0.80	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	13.73	5.12	7.21	2.79	1.16	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	19.91	5.04	7.92	3.36	1.44	0.48	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	15.80	8.05	8.05	3.87	1.79	1.19	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	20.35	8.86	10.29	3.59	1.68	0.48	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.22	5.66	12.74	5.46	1.82	1.01	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	17.42	6.35	6.56	4.71	1.84	1.02	1.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	19.57	8.23	12.90	7.78	2.00	0.67	0.44	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	27.98	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	16.68	5.32	11.00	3.19	2.48	0.71	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	14.58	8.62	10.94	2.98	1.33	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	2.52	3.36	2.52	0.00	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	9.64	8.27	5.51	4.13	0.92	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.96	4.86	13.29	5.19	1.94	0.97	1.30	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	19.27	6.42	13.81	4.82	1.93	0.64	0.96	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	9.12	6.29	10.06	4.09	1.26	1.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	16.22	4.23	16.22	4.94	2.12	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	19.07	6.73	10.09	5.61	2.24	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	3.98	8.76	3.18	1.59	0.00	2.39	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	13.93	11.55	10.19	5.10	2.04	0.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	27.29	5.52	15.60	5.20	3.57	0.32	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	19.88	3.90	15.26	4.97	1.77	0.35	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	32.33	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	15.79	7.90	7.90	0.00	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	20.48	1.46	10.24	3.41	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	23.31	5.45	7.93	6.94	0.00	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.99	6.57	5.63	8.44	0.00	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	12.92	3.64	9.94	4.31	0.99	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	17.63	3.71	5.88	5.57	1.86	0.31	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.23	1.83	10.09	3.36	1.83	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	6.65	2.53	3.33	3.33	0.16	0.48	0.16	0.32
Adipocyte - breast, donor2	11327-117E4	7.54	3.53	2.41	1.28	0.16	0.48	0.00	0.32
Adipocyte - omental, donor1	11473-119C6	10.05	5.60	4.71	1.78	0.38	0.13	0.00	0.38
Adipocyte - omental, donor2	11474-119C7	5.98	4.48	0.75	2.24	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	5.02	3.35	4.35	0.67	0.33	1.00	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	3.83	3.83	1.91	1.91	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	5.50	1.10	0.00	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	4.97	2.71	4.97	3.61	1.81	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	2.61	4.52	3.82	2.26	0.17	0.52	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	12.13	14.08	12.91	4.30	1.56	0.78	0.00	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	11.07	8.49	8.24	5.40	0.26	0.51	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	5.30	7.25	7.81	3.90	0.28	0.28	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	11.17	6.47	7.05	4.11	0.59	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	12.15	9.41	7.48	3.70	0.48	0.48	0.08	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	11.94	10.65	9.68	4.52	1.94	0.65	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	4.80	7.46	3.73	1.60	0.53	1.07	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	3.90	5.56	2.23	2.78	0.00	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.90	2.91	3.74	1.66	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	6.53	4.27	7.53	4.27	1.00	0.25	1.26	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	7.53	3.93	3.60	1.64	0.33	0.65	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	5.18	2.44	3.96	1.83	0.61	0.30	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	30.06	11.49	6.41	4.42	1.55	1.10	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	26.54	11.12	5.74	4.30	1.43	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	10.78	10.78	7.19	2.40	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	25.73	21.77	9.53	7.74	0.18	0.90	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	26.78	16.73	3.35	5.02	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	28.56	12.33	10.48	7.19	1.03	0.82	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	1.72	6.98	5.38	1.49	0.46	0.57	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	1.71	3.43	3.18	0.73	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.29	4.04	1.35	2.70	0.00	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	4.78	3.91	1.30	2.17	0.00	0.43	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	17.12	8.56	0.00	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.77	7.47	3.59	1.79	0.30	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	6.32	2.53	1.26	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.92	4.62	1.98	1.98	1.98	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	5.52	4.55	2.60	2.27	0.00	0.65	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	5.34	7.28	3.40	0.49	0.49	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.34	6.53	5.94	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.90	6.40	2.26	3.01	0.00	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	3.63	7.26	1.45	1.45	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	6.27	0.00	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	7.25	7.58	3.95	1.48	0.33	0.33	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	5.46	2.73	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	6.63	4.37	1.81	1.21	0.00	0.45	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3.21	6.97	1.61	1.07	0.00	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	3.59	7.56	3.21	2.27	0.57	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.82	6.15	3.47	1.60	0.53	0.00	0.53	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	2.93	12.68	2.93	0.98	0.00	0.98	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.81	6.30	2.32	1.66	0.33	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	12.01	3.60	7.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	10.62	0.00	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	6.52	6.52	2.06	1.54	0.17	0.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	20.97	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	4.85	6.80	3.40	1.94	0.00	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.97	6.07	0.76	2.28	0.38	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	6.06	2.42	4.85	0.00	0.00	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	3.42	5.13	3.42	1.71	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	6.20	7.70	4.49	1.92	0.21	0.43	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	6.45	5.68	3.87	2.06	0.00	0.52	1.03	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	2.35	4.69	1.41	1.88	0.47	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	4.50	7.72	2.25	1.29	0.32	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	5.71	5.71	4.28	0.00	0.00	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.36	6.43	0.58	3.51	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.02	6.92	2.11	1.51	0.90	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	7.13	2.38	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	7.12	8.14	2.03	1.53	0.00	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	4.58	6.88	3.82	3.31	0.00	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.99	3.18	1.91	1.91	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.04	6.90	1.73	0.43	0.43	0.00	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.50	8.26	2.75	0.85	0.42	0.42	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.54	8.41	3.48	0.87	0.58	0.00	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6.61	4.72	1.89	3.78	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	5.26	6.95	2.37	1.36	0.00	0.51	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	2.32	0.00	4.63	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	4.23	4.23	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.79	6.43	1.93	1.29	0.00	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.81	6.62	1.80	1.80	0.60	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	6.56	6.56	1.46	0.73	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	6.67	5.52	1.38	1.38	0.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	0.00	0.00	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	6.10	4.58	2.03	1.53	0.00	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	9.08	6.81	2.06	1.24	0.21	0.41	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.90	7.65	5.20	1.84	0.31	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	4.30	6.69	1.91	2.87	0.48	0.00	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.32	6.43	2.22	2.22	0.00	0.22	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	13.73	3.05	1.53	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	5.54	6.65	1.66	0.00	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	6.36	7.15	2.65	1.85	0.26	0.53	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.27	4.00	0.36	2.54	0.36	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	27.14	10.56	9.33	11.67	1.72	0.74	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	30.81	7.87	9.76	8.73	1.71	1.37	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	16.78	16.57	11.54	3.15	0.84	0.84	0.21	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	18.13	13.59	4.88	4.53	0.00	1.39	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	31.38	18.28	8.25	8.41	1.29	0.81	0.32	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	33.41	21.03	7.76	9.84	0.30	1.19	0.45	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	58.49	31.54	29.47	23.97	2.87	2.87	0.46	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	71.41	32.20	30.44	31.57	3.01	2.38	0.50	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	60.31	27.54	26.06	28.56	1.59	2.62	0.11	0.00
Basophils, donor1	12241-129G9	20.40	9.42	3.92	6.02	0.52	1.31	0.00	0.26
Basophils, donor2	12242-129H1	25.62	23.45	8.30	11.91	0.00	0.72	0.00	0.00
Basophils, donor3	12243-129H2	31.60	14.70	6.47	10.44	0.59	0.44	0.29	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	14.66	31.26	15.52	2.16	2.16	3.45	0.22	1.08
Bronchial Epithelial Cell, donor2	11591-120G7	19.20	13.72	5.03	5.49	2.29	2.29	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	64.56	21.52	0.00	0.00	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.34	8.16	9.41	6.28	2.51	0.63	0.00	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	19.34	14.14	8.32	4.78	0.42	1.25	0.00	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	10.59	10.36	5.07	0.92	1.15	0.69	0.23	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	5.76	28.79	16.20	2.34	4.32	1.98	0.36	1.44
Burkitt's lymphoma cell line:DAUDI	10422-106C8	95.22	46.37	14.43	12.37	1.44	1.65	0.72	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	69.41	58.23	34.94	25.39	3.96	2.79	0.93	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	54.04	13.11	22.38	32.94	4.80	3.52	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	20.68	10.34	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	43.39	2.82	2.82	9.58	1.13	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	38.98	7.80	2.60	7.05	0.37	0.56	1.48	0.19
CD14+ Monocytes, donor3	11381-118B4	47.42	9.44	3.07	10.76	0.22	0.88	1.54	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	30.57	13.87	8.21	9.62	0.57	1.70	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	20.85	10.24	6.44	5.69	0.00	0.38	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	24.00	12.16	8.88	9.20	0.66	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	28.62	9.83	2.17	10.12	0.14	0.87	0.58	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	28.36	8.45	2.41	9.05	0.60	0.30	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	38.61	11.37	3.32	10.42	0.00	0.24	0.24	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	22.26	5.86	1.34	6.03	0.50	0.00	0.00	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	21.80	9.66	1.93	4.42	0.55	0.28	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	30.74	7.19	0.99	8.68	0.50	0.50	0.25	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	20.56	5.09	1.96	5.29	0.20	0.20	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	29.38	7.30	1.78	7.48	0.36	0.53	0.53	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	26.55	5.66	1.09	7.83	0.65	0.44	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	27.39	7.26	1.40	7.26	0.94	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	38.02	6.34	1.06	12.14	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	47.70	8.87	2.22	14.42	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	22.91	5.80	1.49	5.21	0.45	0.30	0.15	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	21.35	4.59	0.60	5.79	0.20	0.00	0.20	1.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	25.82	6.87	2.08	6.45	0.21	0.42	0.21	1.87
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	26.77	4.58	0.92	6.41	0.00	0.00	0.69	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	29.41	6.11	1.81	7.01	0.45	0.23	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	28.37	8.29	1.75	7.86	0.00	0.44	0.44	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	21.79	4.84	2.96	5.65	0.54	0.27	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	32.62	7.68	3.31	8.55	0.17	0.00	0.35	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	30.72	5.89	2.10	9.26	0.42	0.84	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	17.82	3.31	1.10	4.59	0.18	0.18	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	18.67	3.17	0.70	4.23	0.00	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	17.11	2.19	2.63	3.07	0.00	1.32	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	22.49	4.18	1.39	4.71	0.17	0.00	0.52	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	30.85	7.43	1.86	6.32	0.74	0.00	1.49	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	27.81	7.11	2.59	7.76	0.43	0.65	0.00	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	15.15	5.32	4.09	6.14	0.82	0.00	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	27.58	7.88	0.46	9.04	0.23	0.00	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	22.97	5.80	0.70	8.12	0.00	0.70	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	15.48	10.03	5.45	7.41	0.44	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	19.63	12.47	5.54	6.47	0.69	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	13.00	8.01	5.63	7.80	0.43	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	40.49	18.84	8.88	12.15	1.56	1.40	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	24.45	10.13	7.34	9.95	0.35	0.70	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	29.21	15.83	6.24	13.38	0.67	1.11	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	10.97	10.72	7.91	6.38	0.51	1.28	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	10.54	13.83	5.71	7.03	0.22	0.44	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	8.63	7.79	6.95	5.05	0.21	0.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	12.19	30.48	4.06	4.06	0.00	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	11.53	16.95	10.17	8.14	0.00	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	14.50	22.78	11.39	8.28	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	23.45	26.65	13.33	8.53	1.07	0.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	17.69	17.69	12.87	8.04	0.00	2.14	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	11.93	17.55	7.72	10.53	0.00	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	8.63	18.82	7.06	8.63	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	21.09	17.14	15.82	11.86	1.32	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	15.62	25.48	10.68	6.58	0.00	0.82	2.47	0.00
CD19+ B Cells, donor2	11624-122B4	16.68	17.41	5.80	5.08	0.73	0.00	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	11.11	24.74	5.05	6.56	0.50	1.51	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	12.12	30.71	18.99	5.66	0.81	3.64	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	9.99	25.97	18.38	4.79	1.20	2.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	80.32	12.05	10.04	13.05	2.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	61.80	11.80	5.62	10.67	0.56	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	51.48	19.92	22.92	24.80	5.64	0.38	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	52.09	18.72	23.90	33.82	3.83	1.80	0.45	0.00
CD4+ T Cells, donor1	11225-116C1	3.57	16.78	10.00	3.57	0.00	1.43	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	4.90	18.37	6.74	2.45	0.00	1.22	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	4.57	16.47	4.88	2.13	0.30	0.30	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	5.87	14.04	9.95	4.08	0.26	1.79	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	4.72	17.52	11.90	5.39	0.45	1.80	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	5.17	16.39	14.37	4.31	0.29	2.01	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1.90	17.07	8.53	5.22	0.00	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	17.56	15.45	0.70	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3.30	13.18	3.30	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	4.77	13.01	6.36	4.77	0.14	0.58	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	7.63	14.40	12.37	4.24	0.51	1.53	0.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	5.96	11.45	9.83	5.64	0.48	0.97	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.90	12.10	4.93	1.79	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	2.10	7.34	5.24	1.75	0.35	0.70	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1.32	12.76	3.52	2.64	0.44	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	12.65	15.60	8.43	9.28	0.42	2.11	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	15.37	20.15	13.51	7.90	0.62	2.70	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	10.02	20.72	11.36	6.01	0.33	2.00	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2.72	25.02	8.43	2.18	0.82	1.09	0.27	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3.22	16.08	9.11	2.68	0.54	1.07	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	17.93	16.14	0.00	1.79	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	14.46	20.21	10.75	8.72	0.37	1.30	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	9.75	17.11	9.96	7.80	0.87	1.08	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	9.04	12.82	9.67	11.98	0.42	1.26	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1.01	13.65	6.07	2.53	0.00	2.02	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	1.30	9.96	6.07	3.47	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	3.05	15.69	3.92	2.61	0.00	0.44	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	3.96	24.25	8.41	3.96	0.49	1.98	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	6.46	18.46	6.46	6.46	0.00	2.77	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1.40	16.75	4.19	4.19	0.00	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	7.48	15.23	6.92	6.65	0.00	2.77	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	4.17	14.72	12.27	2.70	0.25	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	9.24	23.10	13.86	3.08	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	6.45	16.47	10.39	3.58	0.36	1.07	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	11.08	11.08	9.69	4.15	0.00	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	13.42	17.02	9.17	7.53	0.00	0.98	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	7.13	19.52	7.51	4.51	0.38	1.13	0.38	0.38
CD8+ T Cells, donor3	11383-118B6	9.59	21.71	9.85	6.56	0.25	1.26	0.50	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	25.23	19.04	9.63	17.43	2.98	0.69	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	28.04	23.96	12.70	15.58	1.68	0.96	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	29.55	21.34	12.86	14.50	1.92	1.09	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	19.51	23.12	12.31	15.31	3.90	1.80	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	29.76	23.76	11.28	13.20	2.88	1.20	0.72	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	23.42	17.51	11.82	17.05	1.59	0.68	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.68	29.99	12.60	12.39	1.96	0.00	0.65	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	31.32	34.48	11.84	15.27	2.11	1.05	0.79	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	29.31	28.14	12.43	12.66	1.17	1.17	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	27.77	32.00	9.36	17.21	2.42	0.91	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	28.47	35.73	13.36	13.94	2.32	2.32	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	26.38	24.51	9.33	10.39	1.33	0.53	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	44.65	25.83	7.88	10.94	1.75	0.44	5.25	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	42.81	31.42	8.20	11.39	2.28	0.00	3.19	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	32.07	21.63	7.46	10.44	1.49	0.00	5.97	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	28.45	24.49	9.00	14.05	2.16	1.08	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	29.92	25.89	14.39	15.25	3.16	1.44	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	26.87	23.57	10.84	17.44	3.06	0.94	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	27.89	31.37	12.36	10.77	2.85	1.27	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	31.37	31.99	10.76	14.46	1.54	2.46	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	29.17	27.57	9.62	13.14	1.60	0.64	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	32.89	26.39	7.27	12.62	1.53	1.91	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	23.25	25.22	7.09	7.49	3.15	0.79	1.18	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	23.45	34.80	8.32	9.83	3.03	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	24.89	45.77	13.65	8.03	0.80	2.41	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	30.08	55.25	13.99	8.39	2.80	3.50	2.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	38.07	41.07	5.01	6.01	0.00	3.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	25.59	9.14	3.66	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	20.75	9.39	5.43	9.39	0.00	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	19.05	5.16	5.16	3.89	0.21	0.32	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	6.59	3.47	4.16	3.47	0.69	1.04	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	3.55	1.78	2.13	2.49	0.36	0.71	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	3.19	5.35	3.87	1.37	0.23	0.34	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	15.22	2.69	3.58	6.27	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	10.11	4.45	5.66	2.43	0.81	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	30.76	15.49	13.54	9.75	1.95	1.15	0.00	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	19.03	14.32	12.40	5.99	1.92	0.86	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	24.43	12.04	10.27	7.17	1.68	1.15	0.27	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	9.35	13.76	10.09	6.05	1.10	0.83	0.09	0.28
Corneal Epithelial Cells, donor1	11526-119I5	19.98	28.98	10.54	5.05	3.51	1.10	0.00	2.63
Corneal Epithelial Cells, donor2	11606-120I4	10.24	40.95	12.51	4.55	4.55	6.83	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	26.07	30.93	18.15	6.65	3.07	1.79	0.26	3.07
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	17.50	4.95	4.46	8.25	0.33	0.33	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	12.62	3.15	2.84	6.62	0.00	0.63	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	10.35	0.00	10.35	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	19.87	6.70	5.29	7.34	0.97	0.32	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	15.03	30.06	9.91	4.78	0.34	1.37	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	19.59	26.77	9.79	6.53	0.65	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	10.16	26.13	7.26	7.74	0.48	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	21.01	8.34	7.67	5.17	0.67	0.33	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	14.67	7.63	3.52	3.52	2.35	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	23.75	9.62	5.66	7.07	0.28	1.41	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	26.74	4.72	4.33	5.50	1.97	1.18	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	10.47	6.40	6.69	3.20	0.87	0.58	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	21.41	9.18	8.94	5.65	0.71	0.00	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	26.30	10.34	10.34	6.31	1.93	0.35	0.53	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	12.63	9.53	7.54	4.88	1.33	0.44	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	12.17	9.43	7.00	3.65	0.91	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	15.22	6.77	4.23	2.54	1.41	1.13	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	14.26	4.16	5.94	3.86	1.19	0.00	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	11.45	4.69	2.60	2.60	1.04	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	14.32	4.40	5.25	4.40	1.28	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	19.21	7.60	10.80	7.20	1.60	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	15.72	6.29	4.72	2.10	1.05	0.52	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	49.33	16.77	11.68	11.43	2.24	1.74	0.25	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	41.28	6.30	7.82	10.43	1.30	0.22	1.74	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	59.96	5.37	6.11	12.58	2.32	0.61	1.47	0.00
Endothelial Cells - Vein, donor1	11267-116G7	32.99	6.83	5.69	4.55	2.28	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	22.35	11.18	4.19	7.68	3.49	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	30.30	10.83	8.48	8.32	2.51	0.63	0.47	0.00
Eosinophils, donor1	12244-129H3	0.00	15.25	30.49	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	3.30	1.65	1.65	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	7.13	0.00	0.00	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	17.84	25.17	9.77	4.64	1.95	2.20	0.00	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	20.80	12.48	0.00	2.08	4.16	0.00	6.24
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.55	9.03	4.93	0.82	0.41	0.00	1.64	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.28	1.53	2.19	1.09	0.33	0.22	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	14.95	6.39	5.53	3.68	0.33	0.33	0.11	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	16.49	6.55	6.06	2.67	0.85	0.24	0.12	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	8.19	4.91	4.37	1.36	1.36	0.82	0.00	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	11.07	7.70	4.64	1.58	0.11	0.53	0.00	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	13.44	10.54	14.23	1.05	0.79	1.58	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	12.29	8.64	7.64	1.33	0.66	0.33	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	14.97	8.17	6.35	3.63	0.45	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	18.95	5.31	5.31	3.03	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	11.83	7.25	5.84	3.00	0.95	0.47	0.16	0.32
Fibroblast - Cardiac, donor4	11452-119A3	15.46	7.88	7.27	5.15	0.61	1.82	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	15.10	7.23	5.71	2.16	1.14	1.14	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	19.25	4.70	6.52	3.49	0.76	0.61	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	8.98	8.58	4.82	2.55	0.40	0.67	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.08	12.08	8.63	4.31	0.43	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	21.97	11.72	8.79	11.72	2.93	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	24.68	24.22	5.30	4.15	0.23	1.38	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	3.90	44.27	5.09	0.51	0.17	2.37	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	3.29	6.57	0.70	2.82	0.00	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	11.32	10.38	3.77	2.83	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	4.11	7.49	2.54	3.63	0.00	0.48	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	13.34	8.59	4.07	3.05	0.34	0.45	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	18.49	10.29	2.27	4.88	1.22	0.35	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	17.22	12.18	5.68	8.28	0.32	0.81	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	8.33	9.37	0.83	2.29	0.42	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	10.22	8.12	2.10	3.93	0.26	1.05	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	15.02	11.73	5.27	4.22	0.53	0.26	0.40	0.00
Fibroblast - Gingival, donor3	11394-118C8	3.87	9.48	2.22	1.64	0.00	0.58	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	15.58	12.47	4.16	3.12	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	5.64	9.87	3.35	2.47	0.00	0.70	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	23.85	6.39	1.56	5.14	0.16	0.94	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	13.52	6.36	1.76	2.84	0.41	0.41	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	22.23	3.88	2.12	4.59	0.00	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	20.18	7.02	2.92	5.56	0.44	0.29	0.29	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	21.54	9.41	4.50	3.95	0.41	0.55	0.14	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	43.66	7.46	3.07	9.76	0.11	0.44	0.33	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	5.72	17.02	2.93	1.61	0.15	0.29	0.00	0.15
Fibroblast - Lung, donor1	11270-116H1	1.36	8.16	5.44	4.08	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	7.46	11.94	2.98	11.94	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	14.14	10.13	4.43	4.22	1.27	0.63	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	18.33	10.83	6.66	4.17	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	4.20	4.20	4.20	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	8.12	2.80	1.12	1.40	0.84	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	21.52	9.74	7.71	7.31	0.41	0.81	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	7.99	3.99	7.99	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	15.71	14.94	3.88	6.01	0.00	0.78	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	21.69	18.66	2.88	7.89	0.30	0.61	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	7.34	7.04	3.67	1.22	0.00	0.31	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	9.16	5.72	2.29	1.91	0.00	0.00	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	10.53	3.51	1.89	2.43	0.00	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	8.23	9.28	3.60	1.97	0.23	0.81	0.23	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	25.64	7.74	7.41	5.53	0.55	0.66	0.11	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	17.27	13.41	2.03	7.72	0.41	0.61	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	22.05	14.03	5.35	8.69	0.00	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.91	7.12	1.98	2.37	0.40	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	18.26	10.72	9.13	4.37	0.20	0.40	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	5.33	8.70	3.37	1.07	0.00	0.36	0.00	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	8.08	5.91	1.97	1.97	0.39	0.59	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	11.43	6.92	6.02	1.81	0.60	0.90	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	6.15	8.53	2.27	2.81	0.22	0.43	0.00	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	6.58	9.62	4.81	1.27	0.76	1.01	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	7.55	4.10	2.13	0.82	0.33	0.33	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.85	5.61	8.62	3.41	0.80	1.60	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	10.05	4.92	3.82	2.71	0.30	0.40	0.00	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	10.58	9.97	7.56	3.02	0.60	1.81	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	8.20	9.53	3.40	2.15	0.08	0.58	0.00	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	2.91	11.97	2.74	0.34	0.00	0.51	0.00	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	5.58	3.28	4.93	1.64	0.33	0.99	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	7.56	2.88	2.34	2.98	0.11	0.21	0.00	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	11.98	5.90	3.20	2.53	0.51	0.51	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	3.29	4.39	2.67	2.67	0.16	0.00	0.00	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	22.16	0.00	0.00	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	11.33	13.94	15.69	5.23	0.87	4.36	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	20.46	9.53	4.85	3.64	1.21	0.00	0.17	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	15.61	14.57	6.25	2.86	1.04	0.52	0.00	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	15.84	12.78	5.11	2.04	0.77	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	95.69	113.30	53.59	25.26	7.66	2.30	4.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	77.84	143.57	55.51	22.33	8.29	4.47	3.19	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	79.59	147.48	72.46	21.39	16.26	3.99	5.13	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	44.40	44.67	27.85	13.24	4.41	1.38	1.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	36.30	33.34	30.60	7.99	4.34	2.74	1.37	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	69.15	91.73	60.83	20.61	13.67	2.97	5.35	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	36.21	46.52	24.85	11.10	5.29	2.64	1.85	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	34.57	19.89	15.00	7.50	3.91	1.30	1.96	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	70.31	116.75	56.16	15.92	15.48	5.75	3.10	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	51.02	91.72	34.20	14.56	7.35	3.82	0.71	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	48.03	64.03	24.63	13.79	2.59	2.34	0.62	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	44.32	89.99	32.24	11.82	4.30	2.15	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	45.96	32.71	19.82	16.23	3.96	2.23	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	59.80	42.36	28.52	17.72	5.12	1.80	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	49.20	55.91	22.77	15.65	4.88	1.22	1.22	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	34.45	26.01	14.38	9.13	2.05	1.37	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	42.98	37.25	15.20	12.33	1.99	1.49	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	52.46	42.84	19.45	15.08	1.53	1.31	1.09	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	31.62	28.37	12.11	6.80	2.07	2.36	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	51.50	35.29	19.55	11.92	2.38	2.38	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	42.23	48.26	19.88	9.16	1.34	1.12	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	43.35	29.44	17.34	10.69	1.81	1.61	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	47.33	32.23	15.95	11.54	2.21	1.19	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	50.37	41.59	17.11	13.30	2.22	1.68	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	38.08	25.08	14.98	7.49	2.71	1.04	0.00	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.54	16.05	13.32	6.32	2.22	1.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	37.29	21.69	14.72	10.84	1.88	1.55	0.11	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.02	30.87	14.98	9.32	1.66	0.92	0.17	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.10	26.14	13.27	7.55	1.84	1.43	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	29.30	24.76	13.20	8.46	2.68	2.27	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	35.63	27.90	15.45	9.34	1.96	1.04	0.12	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	38.02	23.18	12.17	8.67	1.50	1.17	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	29.10	21.60	11.24	4.85	1.98	1.76	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	38.74	26.94	13.53	9.59	2.46	1.48	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	33.88	28.69	12.97	7.46	1.95	0.81	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	26.62	19.56	13.79	7.06	2.25	0.96	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	36.48	20.66	9.95	7.77	1.99	1.52	0.28	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	35.59	14.87	9.65	5.22	2.53	0.95	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.67	20.98	12.16	8.82	1.82	2.43	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	34.39	18.09	10.45	8.05	1.88	0.94	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	25.69	18.44	6.59	8.34	1.32	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	28.62	19.64	14.31	5.33	1.68	0.84	0.84	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	33.15	14.26	9.07	9.91	1.94	0.74	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	27.54	14.44	9.63	4.55	1.34	0.53	0.80	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	31.83	16.07	6.58	9.95	1.22	0.31	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	33.55	15.03	5.83	8.16	0.91	0.78	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	31.44	8.40	5.96	6.51	0.81	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	21.94	14.01	6.64	6.82	1.11	1.29	0.55	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	26.10	21.71	8.99	6.80	0.22	0.66	0.22	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	27.77	7.93	5.95	4.96	0.00	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	19.92	12.93	8.31	6.20	0.53	1.32	0.40	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	20.98	13.92	5.65	5.25	0.61	0.81	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	23.13	17.03	7.37	3.81	1.02	1.27	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	60.91	134.76	53.75	14.73	4.58	3.38	0.40	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	55.93	112.63	41.91	19.88	6.93	5.55	1.69	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	92.47	150.57	62.40	25.98	8.59	3.68	1.43	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	48.82	134.56	48.19	11.89	4.69	4.38	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	38.99	136.76	37.30	16.39	4.80	3.39	1.41	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	36.90	115.76	39.20	8.30	7.84	3.69	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	84.14	14.85	7.42	7.42	2.47	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	47.19	105.60	38.68	18.18	3.87	5.42	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	32.09	129.96	48.13	6.42	1.60	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	69.55	107.81	34.78	8.69	6.96	6.96	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	42.96	82.35	29.29	14.32	1.95	2.60	2.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	38.30	84.42	34.59	13.59	4.53	2.88	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	53.32	23.33	16.66	6.66	3.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	30.20	52.57	26.85	11.19	3.08	1.96	1.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	43.14	62.10	28.44	7.84	2.29	1.31	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	37.75	59.56	31.04	15.10	3.36	3.36	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	32.76	45.80	23.54	12.09	2.23	1.27	1.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	30.91	51.97	25.47	13.25	2.04	1.36	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	27.15	16.71	12.53	2.09	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	37.23	42.95	32.07	9.16	1.72	1.15	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	25.45	37.29	25.16	7.40	2.07	3.55	0.89	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	28.80	15.25	11.86	5.08	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	33.14	38.52	15.74	6.63	1.66	1.24	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	33.14	53.16	22.32	11.51	2.53	2.07	1.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	15.81	0.00	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	19.22	28.83	16.15	8.46	0.77	1.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	21.51	24.12	13.69	5.22	1.30	1.30	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	17.39	15.38	13.38	10.03	1.34	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	15.03	39.30	25.81	8.86	1.93	2.31	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	42.11	28.07	19.51	12.32	0.34	2.40	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	17.39	22.36	4.97	7.45	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	16.51	27.37	22.65	9.91	0.00	2.83	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	15.09	21.73	22.93	6.03	0.60	1.21	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	26.45	31.03	26.45	6.61	1.02	2.54	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	20.34	31.91	28.32	6.38	1.99	1.20	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	20.23	25.65	24.67	4.93	2.47	0.99	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	22.43	29.51	14.17	11.80	1.18	1.18	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	15.17	35.01	23.92	5.83	2.92	3.50	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	9.66	18.43	17.56	4.83	2.63	2.19	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	11.87	34.76	19.50	5.93	3.39	1.70	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	23.28	30.44	11.94	5.37	1.19	1.79	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	11.65	21.35	11.16	4.37	0.00	0.97	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	7.99	10.27	1.14	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	4.16	3.74	2.91	1.25	0.00	1.25	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	14.62	7.87	2.25	2.25	1.12	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	4.76	5.39	1.27	0.63	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.09	4.18	0.00	0.84	0.00	0.84	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	23.44	20.42	10.79	6.73	2.55	1.51	0.12	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	19.92	21.61	11.48	7.76	1.86	1.69	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	18.20	17.06	11.15	9.56	1.82	2.28	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	19.68	23.28	13.55	7.00	2.08	1.97	0.33	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	21.49	18.27	9.89	5.80	3.22	1.07	0.64	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	16.79	18.08	11.63	8.18	1.94	1.08	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.81	17.81	11.96	6.60	2.62	0.62	0.25	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	18.36	19.90	12.69	9.26	2.74	2.06	0.17	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	16.02	22.11	8.97	4.16	2.88	3.20	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	16.79	6.72	3.92	5.60	1.12	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	33.33	6.92	8.22	8.66	1.30	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	13.22	7.93	5.29	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	19.40	7.05	5.64	5.29	0.35	1.76	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	18.89	8.72	2.91	4.36	0.73	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	24.48	7.69	6.64	7.69	0.17	0.17	0.17	0.00
Hepatocyte, donor1	11523-119I2	0.00	0.00	1.21	1.21	0.00	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	5.39	8.62	3.23	1.08	1.08	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	1.84	3.68	2.45	1.23	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	31.33	50.91	46.34	13.71	3.92	2.61	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	15.21	23.77	12.76	4.37	0.87	1.57	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	10.02	8.92	5.90	3.84	0.96	0.69	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	15.92	31.84	15.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	13.35	6.68	33.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	81.25	81.25	0.00	0.00	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	34.61	34.61	11.08	4.15	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	30.03	17.52	12.51	7.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	106.81	166.16	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	25.63	23.07	43.57	23.07	10.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	27.42	22.85	18.28	4.57	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	34.11	35.74	32.49	16.24	6.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	30.01	23.34	20.01	3.33	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	29.04	10.89	18.15	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	22.50	35.73	41.03	15.88	3.97	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	22.17	19.96	23.28	16.63	2.22	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	36.67	26.19	20.95	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	18.27	22.05	27.71	17.01	6.30	1.26	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	15.47	23.20	12.37	6.19	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	14.63	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	28.43	33.59	26.49	18.74	3.88	3.88	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	28.98	24.15	6.44	9.66	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	23.90	11.95	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	30.97	24.45	34.22	22.00	2.44	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	23.93	34.42	23.09	11.33	5.04	2.10	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	43.12	14.37	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	25.72	28.13	43.40	17.68	6.43	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	22.16	14.77	27.70	17.54	4.62	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	30.16	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	19.35	25.49	23.60	16.99	4.25	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	17.23	9.98	25.40	16.33	6.35	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	29.48	44.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	21.52	25.83	26.90	18.29	5.38	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	21.60	26.68	13.98	3.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	32.86	49.29	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	19.13	14.67	20.41	13.39	3.83	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	14.58	21.87	16.40	0.00	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	31.61	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	29.28	19.28	29.99	13.57	5.71	2.14	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	13.27	26.55	9.95	6.64	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	41.70	20.85	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	26.24	27.47	28.09	18.21	4.63	2.47	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	28.10	33.36	26.34	3.51	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	22.00	9.43	12.57	9.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.03	28.51	34.77	20.86	5.56	2.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	30.98	30.98	11.07	13.28	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	22.69	35.66	29.18	3.24	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	17.44	50.57	24.41	12.21	3.49	1.74	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	29.25	20.25	6.75	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	45.30	20.91	20.91	0.00	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	18.14	40.54	21.34	12.80	3.20	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	6.93	30.48	26.32	11.08	4.16	4.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	31.35	34.20	5.70	5.70	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	14.73	49.70	43.26	18.41	7.36	2.76	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	15.13	24.20	9.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	24.83	37.25	12.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	11.63	42.29	20.09	8.46	4.23	1.06	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	11.83	16.40	11.42	3.26	1.96	0.98	0.16	0.98
Keratinocyte - epidermal, donor2	11349-117G8	6.44	12.30	5.27	0.59	0.59	0.59	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	14.96	19.12	9.84	3.60	1.04	1.23	0.09	0.19
Keratinocyte - oral, donor1	11251-116E9	15.67	51.42	23.84	3.97	3.06	3.86	0.34	2.27
Keratocytes, donor1	11527-119I6	13.41	20.29	5.85	6.53	0.34	1.03	0.00	0.00
Keratocytes, donor2	11607-120I5	18.75	2.34	2.34	7.03	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	7.31	24.90	7.31	1.19	0.00	1.19	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	65.94	10.99	6.59	10.99	2.20	0.00	8.79	0.00
Lens Epithelial Cells, donor1	11529-119I8	12.94	10.79	3.24	7.55	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	18.91	12.80	10.61	4.61	0.58	0.58	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	18.47	15.64	12.41	5.35	1.21	1.11	0.00	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	21.58	11.50	7.59	4.98	2.13	0.83	0.36	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	22.61	5.58	4.47	3.63	0.00	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	22.20	4.56	7.24	5.19	0.79	0.47	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	17.74	5.91	3.23	5.91	0.54	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	21.43	6.30	5.67	5.36	0.63	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	18.44	7.87	5.18	4.85	1.62	0.97	0.43	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	15.18	2.87	6.16	4.51	1.23	0.41	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	17.19	5.31	5.56	6.07	1.26	1.01	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	19.28	6.62	4.22	3.66	1.27	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.47	2.77	2.37	3.56	0.79	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	20.75	5.82	5.82	3.30	1.16	0.78	0.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	16.11	7.78	7.22	3.52	0.74	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	14.29	5.23	6.27	2.79	0.35	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	19.08	5.72	5.96	4.05	1.67	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	20.33	5.91	6.73	4.53	1.37	0.69	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.63	3.39	3.70	3.08	0.62	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	12.78	4.36	3.74	4.05	1.87	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	24.70	8.60	6.77	7.32	0.55	0.37	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	18.43	3.95	4.94	2.96	0.66	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	18.45	6.44	6.44	4.10	2.34	0.59	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	24.64	7.47	7.22	4.48	1.74	0.50	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	13.58	8.24	3.88	2.42	1.94	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	19.66	4.58	6.46	5.92	0.81	0.27	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	22.86	7.87	7.42	6.66	0.76	1.06	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	16.07	1.56	1.56	1.04	2.07	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	19.05	5.23	4.61	6.28	1.68	1.68	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	26.01	6.32	6.47	5.11	2.41	1.20	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.76	6.88	3.44	4.82	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	18.81	4.70	6.02	3.01	0.94	0.38	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	22.90	5.51	5.41	4.35	1.17	0.32	0.21	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	19.38	7.75	2.42	1.45	1.94	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	23.49	5.95	5.95	3.64	0.33	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	22.42	8.30	4.71	5.58	0.99	0.50	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	15.55	5.55	5.18	6.66	2.22	0.74	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	16.80	3.46	4.45	3.95	0.49	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	17.87	7.29	4.81	5.50	1.10	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.90	6.11	4.82	3.54	0.64	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	24.96	5.78	4.56	3.35	1.52	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	22.39	6.72	5.88	4.34	1.26	0.28	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	15.29	4.62	4.27	4.98	1.42	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	11.15	2.91	4.36	4.85	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	25.52	7.31	5.29	4.82	1.40	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	17.19	4.30	4.30	3.58	2.51	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	19.93	4.25	5.23	8.17	0.98	0.98	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	23.31	4.71	7.77	4.47	1.18	0.47	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	17.82	8.54	5.69	5.32	1.49	0.12	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	13.32	4.61	2.56	4.61	0.26	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.62	8.06	6.56	4.18	0.30	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	20.39	6.80	11.33	2.27	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	22.25	19.18	10.74	9.97	1.53	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	23.01	14.84	7.42	4.45	0.74	2.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	32.58	26.23	13.54	11.42	2.54	1.69	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	28.84	17.58	10.55	3.52	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	17.75	14.94	9.34	6.54	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	30.40	18.03	11.34	7.73	0.52	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	28.55	10.71	11.89	7.14	3.57	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	39.13	18.10	8.14	9.95	0.68	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	37.81	20.07	10.76	10.18	1.74	1.74	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.96	19.36	7.65	6.75	0.90	1.80	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	43.08	27.10	11.52	10.70	0.95	1.90	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	33.89	22.08	17.46	11.81	3.59	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	27.52	22.23	10.23	8.82	1.76	1.41	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	24.65	11.99	8.66	8.66	0.67	0.00	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	42.79	18.85	16.81	8.66	1.53	2.04	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	33.08	19.48	10.94	8.27	1.33	1.07	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	37.60	22.67	13.42	10.77	1.89	0.94	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	40.50	17.18	13.50	8.59	0.61	3.68	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	35.88	22.83	16.31	10.60	1.63	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	36.65	21.03	13.12	9.79	1.87	1.25	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	37.55	16.54	14.29	13.17	1.12	0.84	1.40	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	38.12	16.49	11.33	10.30	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	36.58	25.55	13.06	9.87	2.32	0.87	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	45.74	20.03	11.06	8.97	1.79	1.20	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	25.45	20.47	11.62	10.51	1.11	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	44.54	29.34	20.50	10.96	2.47	1.06	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	37.62	21.02	14.01	8.11	1.11	1.84	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	27.63	14.97	8.06	4.61	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	35.31	23.41	13.43	11.90	0.77	2.30	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	28.87	15.29	18.68	8.49	2.26	1.13	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	27.90	18.05	13.13	8.20	3.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	42.48	22.14	14.46	5.42	1.81	1.36	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	37.34	28.73	14.36	2.87	0.00	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	28.38	22.41	14.19	11.20	2.99	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	43.85	30.84	12.26	10.40	1.11	1.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	31.88	20.25	11.20	9.05	0.86	1.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	30.83	15.41	11.13	11.99	2.57	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	32.65	26.65	12.66	9.00	2.67	2.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	38.01	11.46	7.84	9.65	1.81	2.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	34.13	22.75	8.53	9.95	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	41.25	27.50	14.09	10.31	1.37	2.41	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	37.57	19.32	15.57	14.49	1.61	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	36.36	20.20	10.77	9.43	2.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	40.00	25.56	16.67	7.78	0.37	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	36.05	17.44	4.65	3.49	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	30.67	26.44	9.52	10.58	3.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	35.21	28.41	16.41	11.60	3.60	2.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	37.07	18.17	13.81	7.27	2.18	1.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	23.00	16.10	15.33	6.90	0.77	3.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	32.06	19.73	10.85	12.33	1.48	1.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	23.52	14.11	14.11	7.53	0.94	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	28.66	16.09	15.08	5.03	1.51	1.01	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	38.75	26.59	15.77	11.72	1.80	1.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	37.86	8.61	13.77	6.88	3.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	25.83	20.93	12.91	9.80	2.67	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	33.24	17.60	15.25	6.65	1.56	1.96	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	26.39	21.77	8.58	8.58	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	30.10	18.68	11.94	5.71	2.59	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	42.88	22.32	18.82	14.88	2.63	2.63	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	33.55	21.80	6.15	7.27	0.00	1.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	30.47	17.22	15.46	8.39	0.88	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	38.19	19.67	13.11	8.87	0.77	1.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	30.38	14.18	18.23	11.65	0.51	0.51	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	37.01	19.71	11.05	11.05	1.44	2.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	36.97	23.06	13.52	7.55	1.99	1.59	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	35.85	12.15	3.04	6.68	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	24.21	11.07	10.38	5.53	0.00	2.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	38.76	20.14	16.34	10.26	1.90	1.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	30.47	14.46	11.36	6.20	0.52	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	26.60	19.35	12.09	10.88	1.21	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	45.00	22.50	13.94	10.14	0.63	0.63	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	37.85	25.59	12.79	7.46	0.53	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	24.71	8.62	10.34	10.92	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	40.11	31.37	15.94	8.74	4.11	1.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	37.49	17.68	12.03	14.15	2.12	3.54	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	26.10	15.89	12.48	9.08	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	38.27	25.38	17.89	10.40	0.83	1.66	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	31.32	27.41	7.83	10.96	0.78	2.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	22.97	16.70	9.60	9.19	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	42.75	25.56	14.87	10.69	0.93	1.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	35.46	14.05	10.70	5.35	0.67	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	33.15	17.11	13.37	6.95	1.07	3.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	40.01	20.61	17.38	12.12	1.62	2.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	41.30	14.68	8.26	13.77	1.84	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.90	16.89	6.22	8.00	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	43.88	23.93	13.68	8.55	2.85	2.85	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	51.38	13.80	10.74	12.27	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	32.83	11.49	10.40	10.40	1.64	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	46.33	18.71	11.58	13.36	1.78	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	64.47	18.72	11.18	12.48	1.56	1.30	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	38.46	11.94	11.27	12.60	1.33	0.00	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	41.57	39.49	43.65	2.08	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	22.11	9.57	6.84	7.98	1.37	0.68	0.68	0.23
Macrophage - monocyte derived, donor2	11313-117C8	24.59	3.49	1.65	5.51	0.92	0.18	0.37	0.18
Macrophage - monocyte derived, donor3	11389-118C3	31.07	3.93	4.98	9.57	0.13	0.52	0.52	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	9.56	3.72	2.12	4.25	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	8.08	5.86	2.85	2.22	0.48	0.48	0.00	0.48
Mallassez-derived cells, donor3	11930-125I4	12.65	10.01	3.89	2.78	0.83	0.83	0.00	0.56
Mammary Epithelial Cell, donor1	11273-116H4	25.11	23.52	7.87	4.68	0.70	0.90	0.00	0.70
Mammary Epithelial Cell, donor2	11350-117G9	16.21	15.06	6.08	5.79	1.16	0.58	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	16.21	14.97	13.22	2.74	1.50	1.00	0.25	0.75
Mast cell - stimulated, donor1	11487-119E2	86.78	5.42	3.39	12.88	1.36	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	63.91	12.76	11.57	20.55	2.49	0.76	0.11	0.11
Mast cell, donor2	11565-120D8	37.15	10.10	11.29	22.29	1.19	0.59	0.30	0.00
Mast cell, donor3	11566-120D9	22.74	9.23	10.58	18.46	1.80	0.68	0.68	0.23
Mast cell, donor4	11567-120E1	37.94	8.69	11.52	15.78	1.06	0.53	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	17.08	11.53	14.53	13.31	2.11	1.11	0.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	59.54	21.01	18.68	15.76	0.58	0.00	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	32.35	8.72	14.68	15.26	2.29	0.57	0.00	0.11
Mast cell, expanded, donor8	11941-126A6	60.59	23.93	18.75	17.24	2.68	1.51	0.00	2.51
Melanocyte - dark, donor1	11502-119F8	18.61	5.77	6.17	8.36	1.29	0.70	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	20.42	14.54	7.96	8.65	0.35	1.04	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	29.12	4.71	9.13	4.56	2.17	0.51	0.07	0.07
Melanocyte - light, donor1	11274-116H5	10.58	4.23	5.64	3.29	2.35	0.71	0.00	0.24
Melanocyte - light, donor2	11351-117H1	16.38	2.73	8.19	2.05	2.73	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	19.08	5.20	9.54	3.47	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	33.42	6.35	13.12	6.56	3.23	1.04	0.10	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	27.43	5.38	11.56	5.38	3.23	0.27	1.61	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	23.30	7.23	8.57	3.48	2.14	0.00	0.27	0.27
Meningeal Cells, donor1	11493-119E8	23.94	12.41	12.28	9.68	1.36	1.61	0.00	0.00
Meningeal Cells, donor2	11573-120E7	14.08	6.60	4.84	6.16	1.76	1.32	0.00	0.00
Meningeal Cells, donor3	11654-122E7	25.35	13.77	14.26	11.90	2.45	1.30	0.16	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	16.82	7.70	5.13	5.13	0.57	1.14	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	10.16	9.66	3.22	2.42	0.70	0.10	0.10	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	2.63	1.31	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	6.54	1.31	3.92	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	25.12	8.61	10.05	10.76	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	8.05	7.84	2.96	1.06	0.00	0.42	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	7.54	8.04	2.01	3.52	0.50	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	20.88	8.35	5.05	8.13	1.10	0.66	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	29.95	3.65	3.65	6.58	0.00	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	17.80	5.52	6.34	7.16	0.61	1.02	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	5.54	6.23	2.63	2.22	0.55	0.14	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.43	6.32	1.86	1.86	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	9.08	12.76	5.00	2.11	0.13	1.32	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.04	8.01	2.08	3.26	0.00	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	14.01	4.67	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	24.98	8.97	6.40	4.48	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	29.77	7.80	6.38	12.05	0.35	1.06	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	7.82	13.13	5.32	0.94	0.31	0.31	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	15.24	5.81	5.08	7.26	1.45	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	10.87	2.92	3.18	2.12	0.00	0.00	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	16.52	2.50	2.50	1.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	10.84	5.42	3.54	2.31	0.79	0.79	0.14	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	48.61	0.00	2.70	9.45	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	20.44	5.42	5.42	7.14	1.48	0.25	2.22	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	23.85	1.47	3.53	6.48	1.18	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	55.31	0.00	0.00	13.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.95	2.79	3.41	8.37	0.62	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	18.67	1.66	3.73	7.68	1.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	48.64	2.32	0.00	4.63	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	15.52	4.50	4.25	6.01	0.50	0.50	1.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	42.82	3.26	3.26	6.52	0.00	0.93	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	175.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	15.44	4.67	2.85	6.50	0.61	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.53	4.36	5.54	7.13	0.40	0.00	0.00	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	94.07	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	1.77	1.77	2.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	23.56	2.66	4.18	5.32	1.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	75.01	0.00	0.00	13.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.43	4.67	2.76	5.52	0.42	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	40.52	0.92	0.00	3.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	15.50	3.87	2.68	8.64	0.30	0.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	67.07	0.00	0.00	11.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	339.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.30	4.27	1.51	6.27	0.25	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	27.57	2.61	2.38	6.65	0.48	0.24	1.19	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	42.57	1.11	0.55	6.63	0.00	0.55	2.21	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	10.13	2.07	0.69	3.45	0.23	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	25.87	0.84	2.31	5.68	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	20.38	2.24	1.22	3.26	0.41	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	12.66	1.93	1.50	3.86	0.43	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	29.79	2.67	2.89	5.56	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	103.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	15.55	2.41	1.10	1.97	0.00	0.00	0.66	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	46.64	0.51	1.52	6.59	0.00	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	57.99	4.97	1.66	3.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.60	0.82	1.36	2.17	0.00	0.00	0.82	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	37.35	3.23	1.18	3.82	0.29	0.29	0.88	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	31.62	0.00	0.00	3.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	12.01	1.44	1.44	2.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.41	1.20	1.60	2.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	41.14	2.74	2.74	6.86	0.00	0.00	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.51	1.50	0.50	3.00	0.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	42.81	0.00	0.00	4.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.01	2.63	1.31	2.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	38.63	0.00	1.10	6.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	29.46	2.56	1.28	5.12	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.93	2.48	1.74	3.72	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.92	0.70	0.70	4.18	0.00	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	37.57	0.00	4.42	17.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	7.86	4.44	2.05	2.39	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	25.38	1.75	1.75	3.06	0.00	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	39.77	3.20	1.07	6.75	0.00	0.00	1.07	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	11.78	6.45	3.37	3.65	0.00	0.28	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	15.38	2.91	1.25	3.74	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	24.48	4.66	0.00	5.83	0.00	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.76	5.73	1.81	5.73	0.00	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	21.70	5.84	2.50	5.01	0.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	7.22	28.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	5.54	6.46	2.77	0.92	0.00	0.00	2.77	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	29.03	5.69	2.28	8.54	0.00	0.00	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.09	4.42	1.80	4.97	0.28	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.26	5.96	3.11	3.63	0.26	0.26	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	22.31	6.86	3.86	5.15	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	26.68	3.18	0.64	2.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.07	4.54	1.33	4.27	0.27	0.53	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.17	3.59	2.69	4.49	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.44	3.67	2.26	5.79	0.42	0.00	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	9.56	4.78	3.19	2.87	0.00	0.64	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	20.12	6.41	4.64	7.30	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.93	3.03	1.14	6.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.23	6.82	3.13	5.40	0.57	0.28	1.14	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	15.98	5.16	3.69	6.64	0.00	0.49	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	24.76	1.30	1.30	2.61	0.65	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.00	4.41	3.82	7.06	0.29	0.59	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	23.64	5.77	1.73	8.36	0.29	0.58	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	18.13	5.36	4.12	5.36	0.00	0.00	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.00	8.64	3.87	7.15	0.00	0.30	1.49	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	15.07	7.53	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	3.56	5.35	3.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	22.34	10.19	5.26	8.21	1.31	0.33	0.66	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	16.83	10.52	1.05	8.42	0.00	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	22.34	8.30	6.92	5.14	0.79	0.79	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	25.15	3.73	5.59	9.31	0.00	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	16.15	7.89	4.13	4.88	0.38	0.38	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	18.91	6.13	2.66	8.52	0.27	0.27	0.53	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	18.89	7.69	3.85	5.88	1.58	0.23	0.00	0.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	24.31	3.68	2.21	5.16	1.47	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	20.89	9.89	5.13	6.96	1.47	0.37	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	10.89	3.11	9.33	0.00	1.56	4.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	11.22	5.34	1.60	2.14	0.53	0.00	0.00	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	7.73	7.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	23.23	8.08	3.03	4.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	12.23	4.64	3.37	5.06	0.42	0.42	1.26	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	10.90	0.00	0.00	4.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	1.27	0.64	1.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.00	1.62	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	15.10	3.02	0.00	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	91.36	5.71	0.00	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	75.04	6.52	0.00	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	66.53	0.00	4.75	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	13.14	4.74	2.80	4.09	0.43	0.65	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	4.70	6.79	6.27	1.57	1.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.02	2.67	2.00	1.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.52	0.83	1.67	2.50	0.00	0.00	1.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	7.61	5.89	6.08	5.70	0.76	0.57	0.38	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	35.11	3.19	0.00	3.19	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	0.68	0.68	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	3.68	1.84	3.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.04	3.77	2.09	0.84	0.42	0.42	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	11.85	3.25	2.32	2.56	0.93	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	6.76	4.32	5.40	2.70	0.27	0.27	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	7.78	7.36	4.41	2.94	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	44.54	0.00	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4.96	4.47	3.97	1.49	0.50	0.50	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.95	7.04	4.60	3.79	0.27	0.54	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.76	3.85	2.72	0.45	0.68	0.00	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.45	4.90	4.74	2.29	0.49	0.00	0.49	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	7.84	8.57	4.92	3.28	0.55	0.55	1.09	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.30	2.65	4.24	1.59	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.21	4.20	2.40	1.80	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4.59	15.42	5.25	1.31	0.66	0.66	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.48	2.76	2.93	1.14	0.81	0.16	0.81	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	10.41	7.41	3.70	3.70	0.00	0.53	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	5.63	7.74	5.63	2.11	0.00	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.11	4.14	3.22	0.92	0.00	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	8.35	4.18	6.43	3.86	0.32	0.64	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	4.83	4.83	5.86	2.07	0.69	0.34	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	7.59	2.53	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	13.37	7.57	4.23	2.23	0.22	0.22	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	10.58	6.77	4.66	1.69	1.27	0.85	0.00	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.07	4.98	5.70	2.61	0.71	2.14	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	10.73	6.44	9.44	3.00	0.43	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	18.06	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	8.66	5.00	3.00	2.00	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	18.49	5.86	3.61	0.90	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.73	2.78	10.32	3.17	0.79	1.19	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	8.36	3.71	2.79	1.86	0.00	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	9.84	6.43	6.05	1.89	0.38	0.38	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	18.90	3.26	3.26	1.63	0.98	0.33	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	8.28	3.92	3.05	1.31	0.00	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	15.38	5.43	3.17	2.71	0.45	1.36	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	8.82	6.17	6.17	2.65	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	10.64	3.32	8.64	0.66	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.40	1.98	5.95	1.49	0.99	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.48	1.91	3.45	1.15	0.00	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	9.38	12.10	13.61	3.63	0.91	1.21	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	12.16	7.51	5.53	3.54	0.44	0.22	0.22	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	17.62	3.39	7.45	2.03	0.68	0.00	1.36	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	10.22	0.00	5.11	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.75	5.49	7.32	1.22	0.61	1.22	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	20.46	4.72	2.83	2.20	0.94	0.31	0.63	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	7.87	5.15	4.24	1.51	0.30	1.21	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	16.61	3.96	6.33	0.79	0.00	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	7.94	5.67	9.07	4.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	12.30	2.24	2.24	1.99	0.62	0.37	0.25	0.00
Myoblast, donor2	11322-117D8	11.12	8.63	6.71	3.26	0.58	0.58	0.00	0.38
Myoblast, donor3	11398-118D3	12.78	4.04	2.35	2.35	0.50	0.34	0.34	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	88.58	29.77	23.06	15.91	4.23	1.31	4.67	0.15
Natural Killer Cells, donor1	11230-116C6	14.15	16.30	8.61	4.00	0.31	1.85	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	7.84	18.39	5.73	3.32	0.00	0.60	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	11.78	15.46	6.07	3.87	0.74	1.10	0.18	0.00
Neural stem cells, donor1	11275-116H6	29.76	25.41	9.07	8.71	2.18	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	9.63	9.63	5.78	3.85	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	14.79	23.90	12.52	4.55	1.14	1.14	0.00	0.00
Neurons, donor2	11574-120E8	7.49	21.14	8.15	3.52	0.66	1.10	0.00	0.00
Neurons, donor3	11655-122E8	11.51	20.55	4.93	1.64	0.00	0.00	0.82	0.82
Neutrophils, donor1	11233-116C9	10.21	1.86	0.00	3.71	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	17.39	0.00	0.00	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	6.72	1.22	0.00	0.61	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	3.56	13.65	7.36	0.83	0.36	1.07	0.24	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	5.21	13.02	6.84	1.63	0.65	0.98	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	3.01	4.21	5.21	1.40	0.60	0.60	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	7.57	9.22	4.96	1.38	0.55	0.41	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	7.96	7.38	6.08	2.03	0.72	0.00	0.14	0.14
Olfactory epithelial cells, donor3	11935-125I9	5.68	8.17	2.72	1.82	0.57	0.91	0.11	0.34
Olfactory epithelial cells, donor4	11936-126A1	13.34	10.13	9.84	2.92	1.17	0.19	0.49	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	9.63	12.04	6.62	3.61	1.81	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	8.30	9.36	4.47	1.70	0.43	1.28	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	9.14	6.86	6.86	1.14	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	1.86	6.21	3.72	0.62	0.00	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	22.87	25.21	11.14	5.86	0.98	1.95	0.20	0.00
Osteoblast, donor2	11354-117H4	21.77	12.64	11.24	7.02	2.11	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	30.39	6.75	7.11	7.64	0.89	0.18	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	4.80	6.74	2.19	1.43	0.00	0.25	0.00	0.00
Pericytes, donor1	11491-119E6	6.01	9.90	5.01	2.00	0.22	0.45	0.00	0.11
Pericytes, donor2	11571-120E5	7.24	7.70	7.24	2.94	0.00	1.81	0.00	0.00
Pericytes, donor3	11652-122E5	19.53	3.26	7.32	5.09	0.41	0.41	0.00	0.00
Perineurial Cells, donor1	11499-119F5	11.64	9.38	6.78	4.75	0.68	0.79	0.00	0.00
Perineurial Cells, donor2	11579-120F4	30.00	17.76	8.47	8.83	1.20	0.83	0.00	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	46.85	14.34	10.52	8.29	0.32	1.27	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	32.32	15.43	8.08	5.88	0.49	0.98	0.73	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	31.97	15.53	5.95	8.54	1.16	0.91	0.52	0.00
Placental Epithelial Cells, donor1	11278-116H9	14.11	11.00	10.28	2.63	0.72	0.00	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	15.52	5.54	6.65	2.22	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	22.18	26.50	7.07	7.46	0.79	1.37	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.28	2.53	1.90	2.85	0.00	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	14.63	4.88	5.63	2.44	0.38	0.56	0.00	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	12.92	4.96	5.48	2.35	0.39	0.39	0.13	0.52
Preadipocyte - breast, donor2	11328-117E5	14.63	4.73	4.50	1.58	0.68	0.23	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	13.53	8.63	5.97	2.88	0.21	0.64	0.00	0.64
Preadipocyte - omental, donor2	11329-117E6	10.04	5.24	4.80	2.18	0.44	0.44	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	16.04	4.30	4.01	3.29	1.29	0.72	0.29	0.29
Preadipocyte - perirenal, donor1	11469-119C2	8.86	1.97	0.98	1.97	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	19.35	6.76	2.46	4.30	0.31	0.00	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	26.74	13.99	4.25	7.79	1.24	0.53	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	13.96	8.51	3.41	6.98	1.02	0.51	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	17.23	9.69	4.94	5.87	0.47	0.93	0.09	0.09
Preadipocyte - visceral, donor2	11357-117H7	11.04	7.82	4.14	2.30	0.92	1.84	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	13.48	3.97	3.45	3.55	0.21	0.52	0.00	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	16.90	25.80	7.39	5.28	0.60	0.60	0.15	0.00
Prostate Epithelial Cells, donor2	11331-117E8	17.74	7.99	5.82	3.11	0.95	0.54	0.27	0.41
Prostate Epithelial Cells, donor3	11404-118D9	7.47	19.29	12.80	0.61	2.02	0.86	0.55	1.71
Prostate Stromal Cells, donor1	11254-116F3	22.10	10.82	5.24	4.67	0.34	0.34	0.23	0.00
Prostate Stromal Cells, donor2	11332-117E9	24.92	13.09	5.20	5.74	0.36	0.36	0.18	0.00
Prostate Stromal Cells, donor3	11405-118E1	5.63	6.57	1.98	1.77	0.21	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	28.10	13.14	8.39	5.84	2.92	1.09	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	14.97	7.14	7.21	2.56	1.11	0.28	0.00	0.00
Renal Epithelial Cells, donor1	11517-119H5	34.49	8.12	8.62	10.65	1.01	1.52	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	40.55	13.52	12.80	10.67	0.71	0.71	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	21.91	15.24	15.35	7.62	1.80	0.53	0.11	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	23.15	3.40	5.45	5.45	0.68	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	18.46	7.55	7.68	6.20	1.21	0.81	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	39.30	13.10	7.99	8.66	1.11	1.33	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	19.30	11.31	5.99	4.66	1.33	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	28.17	11.66	7.70	9.02	0.66	1.32	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	26.96	10.03	10.66	7.52	1.88	1.88	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	29.96	10.54	9.43	7.49	0.28	1.39	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	32.75	10.20	9.93	8.32	1.34	0.81	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	21.51	9.28	5.06	4.22	0.84	0.84	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	46.28	17.55	11.96	9.45	0.39	0.58	0.58	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	15.30	10.11	9.59	2.07	1.30	1.30	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.06	12.51	15.63	4.83	2.27	0.85	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	29.84	9.26	8.23	4.12	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	6.77	15.31	15.31	2.51	1.76	1.76	0.00	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	7.62	15.77	6.55	2.94	1.07	1.07	0.13	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	63.43	44.67	23.23	22.34	0.89	3.57	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	23.67	111.17	59.99	16.51	1.10	6.05	1.65	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	48.72	52.78	28.42	19.14	3.48	1.74	1.74	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	46.81	38.23	25.22	18.33	1.56	1.95	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	53.33	41.21	25.72	21.35	2.78	2.09	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	68.71	55.43	31.57	25.43	4.46	3.12	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	40.44	57.56	41.06	18.98	3.10	3.85	0.25	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	46.27	39.51	27.04	25.41	3.61	3.73	0.58	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	66.10	68.42	37.67	22.19	4.62	2.77	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	39.29	28.48	24.23	17.66	1.92	2.46	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	42.96	42.81	22.39	21.33	3.48	2.87	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	76.34	53.76	38.53	30.28	4.84	5.02	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	38.02	29.41	21.81	24.24	1.43	3.01	0.29	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	47.11	44.54	26.40	23.18	4.83	2.68	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	60.41	44.70	31.86	24.12	2.88	2.88	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	43.21	25.62	17.21	24.28	0.96	1.15	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	57.11	42.02	25.43	21.99	2.79	3.07	0.75	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	71.22	59.19	43.03	26.87	4.13	4.70	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	47.77	27.74	18.45	19.11	1.46	2.92	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	59.09	41.76	24.53	23.65	3.41	1.75	0.97	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	58.82	52.32	29.03	25.40	4.58	2.86	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	42.29	26.70	20.50	17.30	1.50	1.50	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	56.34	44.57	29.15	25.23	4.48	2.24	1.12	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	73.49	43.41	26.49	23.24	3.59	3.25	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	45.40	31.00	22.06	20.24	1.09	2.19	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	58.01	43.04	25.26	26.00	2.94	1.59	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	73.74	52.12	30.09	25.52	4.03	3.76	0.81	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	42.69	32.08	24.06	23.12	2.59	3.07	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	50.99	39.48	24.40	21.43	3.77	1.79	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	76.47	49.34	31.80	25.96	4.91	3.51	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	42.09	21.56	25.30	25.09	1.87	3.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	57.74	32.30	22.56	26.10	2.21	2.65	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	85.02	40.31	24.02	25.69	3.76	2.09	1.67	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	48.99	23.15	24.63	22.88	1.21	2.42	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	74.59	28.95	21.63	21.97	2.72	1.19	1.19	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	86.95	43.76	28.53	28.73	4.43	2.89	1.54	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	46.25	23.04	22.70	29.23	1.03	3.61	0.69	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	86.42	32.65	22.22	33.88	2.74	2.33	1.51	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	90.62	44.49	28.89	36.28	4.93	2.46	1.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	42.78	30.17	18.75	22.67	1.36	2.39	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	76.64	39.80	21.60	30.92	1.92	3.11	0.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	72.77	47.18	26.39	35.18	1.60	1.87	2.67	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	37.47	43.14	27.10	15.76	1.66	3.46	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	63.81	65.00	27.86	28.57	2.86	5.00	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	78.00	62.88	33.86	29.02	3.22	4.64	3.63	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	38.14	39.27	22.41	18.27	1.70	3.77	0.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	67.08	87.69	31.44	21.31	2.79	3.49	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	78.27	50.77	23.57	22.97	1.21	1.81	3.93	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	37.57	34.27	22.27	16.52	1.59	2.08	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	127.65	107.42	53.27	31.00	3.06	7.13	0.73	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	83.96	69.97	31.64	18.86	3.04	6.08	0.61	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	46.72	33.76	30.14	16.88	0.30	3.01	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	87.53	87.53	41.17	16.74	2.71	6.11	0.45	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	78.48	82.07	44.93	25.76	3.00	4.19	1.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	39.44	55.02	34.48	12.40	1.77	3.42	0.00	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	71.72	77.48	38.21	21.77	3.42	2.35	0.64	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	83.54	74.52	55.29	21.64	1.80	6.01	2.40	0.00
Schwann Cells, donor1	11498-119F4	30.47	7.33	9.03	7.33	1.13	0.56	0.00	0.19
Schwann Cells, donor2	11578-120F3	3.40	13.61	6.80	3.40	3.40	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	13.58	14.68	8.98	4.60	0.66	2.19	0.00	0.22
Sebocyte, donor1	11220-116B5	36.15	29.03	11.50	7.67	0.55	2.74	0.00	1.10
Sebocyte, donor2	11301-117B5	17.46	22.52	13.33	5.51	0.00	1.84	0.00	1.38
Sebocyte, donor3	11378-118B1	11.54	19.58	10.51	1.86	1.86	1.86	0.21	1.44
Sertoli Cells, donor1	11255-116F4	9.94	1.66	13.25	4.97	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	0.00	8.47	0.00	0.00	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	7.92	17.16	13.72	2.11	1.50	1.67	0.00	0.26
Skeletal Muscle Cells, donor2	11358-117H8	2.89	7.95	5.78	1.45	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	20.90	8.36	8.36	9.20	2.51	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	20.11	7.54	10.37	7.23	1.10	0.63	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	17.09	9.07	8.32	6.84	1.19	1.19	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	30.32	8.16	7.54	10.93	1.23	0.92	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	13.61	15.37	7.56	4.03	0.88	1.76	0.50	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	9.85	9.85	7.71	4.42	0.57	0.57	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	36.41	15.87	11.91	9.52	1.98	1.29	0.69	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	13.73	16.43	12.64	4.63	1.43	1.26	0.08	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	14.48	9.41	5.07	2.17	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.60	8.67	3.72	2.61	0.28	0.28	0.00	0.00
Skin - palm, donor1	10286-104F7	13.43	0.00	13.43	8.06	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.40	7.35	5.62	2.02	0.72	0.72	0.14	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	6.54	13.09	4.91	1.64	0.82	0.82	0.00	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	16.36	9.61	5.45	2.60	1.17	1.17	0.39	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	22.94	18.07	5.70	3.20	0.70	1.39	0.42	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	26.16	21.38	1.83	3.38	0.42	1.13	1.13	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	30.24	29.18	16.07	2.54	1.90	2.75	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	14.32	20.01	4.12	1.42	0.97	1.05	1.20	0.97
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.33	3.39	1.54	1.23	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	8.23	5.56	5.11	0.89	0.44	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	5.88	4.11	1.76	2.35	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	23.87	13.70	14.81	9.94	1.10	1.33	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.60	3.54	3.15	3.94	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	8.50	3.09	3.09	2.32	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	10.01	14.01	4.00	3.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.85	5.46	4.26	2.40	0.40	0.80	0.00	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	9.09	2.44	2.88	3.32	0.00	0.44	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.96	2.18	2.82	2.30	0.13	0.38	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	13.67	3.91	3.91	1.95	0.00	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	14.77	4.13	4.73	5.02	0.30	0.59	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	15.52	4.70	1.71	2.85	0.43	0.43	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	15.45	5.04	4.88	3.90	0.65	0.33	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	5.48	17.96	8.83	1.83	0.30	0.61	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	6.82	7.58	6.06	3.28	0.76	1.01	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	440.69	269.31	0.00	18.36	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.25	3.34	2.86	0.95	0.95	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	17.70	5.31	1.77	3.10	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	14.21	5.60	2.37	3.01	0.00	0.22	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.95	7.45	4.62	5.77	0.21	0.63	0.21	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	15.93	4.95	4.18	2.94	0.93	0.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	19.40	2.16	1.08	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.67	3.59	1.49	2.99	0.30	0.60	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	25.95	9.90	6.49	12.29	0.00	0.68	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	10.99	21.12	6.28	2.12	0.47	0.94	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	10.77	5.84	3.02	2.52	0.10	0.50	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	14.11	9.78	5.92	2.05	0.00	0.68	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.25	3.02	3.02	0.60	0.00	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	43.18	12.72	9.54	14.04	0.79	1.06	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	7.19	6.52	1.73	1.73	0.27	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	11.65	8.26	3.38	2.00	0.13	0.38	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	1.78	2.79	2.54	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	14.62	4.22	3.62	4.07	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.75	4.50	2.25	1.50	0.75	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	56.86	12.92	36.18	19.38	7.75	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	22.32	13.02	6.05	6.05	1.40	0.93	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.07	3.53	3.03	1.01	1.01	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.46	3.45	1.88	0.63	0.31	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.60	3.24	1.77	1.47	0.88	0.88	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	27.74	7.58	6.16	9.91	0.58	0.58	0.25	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.07	13.55	2.80	2.80	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	14.82	5.47	3.02	4.32	1.15	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	21.67	5.86	3.31	3.06	0.25	0.76	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.60	7.71	3.20	1.50	0.75	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	13.14	6.29	5.73	5.31	0.84	0.98	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	12.65	6.28	4.86	2.68	0.59	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.43	3.81	1.43	0.48	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	13.95	7.83	3.67	2.94	0.49	0.00	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	12.37	2.87	2.43	3.76	0.22	0.44	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	2.05	8.48	3.51	1.76	0.00	0.29	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	6.03	15.16	4.28	1.17	0.19	0.19	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	5.55	3.44	1.32	1.06	0.26	0.26	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	1.12	10.41	2.23	0.37	0.00	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	3.95	4.31	1.44	0.36	0.00	0.36	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	2.27	1.42	0.85	0.57	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	12.21	4.33	1.97	4.73	0.00	1.18	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	3.81	4.32	2.29	1.27	0.00	0.25	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	2.40	9.18	4.79	1.20	0.00	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	3.34	7.52	2.51	2.09	0.00	0.42	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	3.21	9.63	2.29	0.92	0.00	0.00	0.00	0.46
Synoviocyte, donor1	11291-117A4	11.61	5.55	4.21	1.85	0.00	0.00	0.00	0.00
Synoviocyte, donor2	11368-117I9	4.53	5.87	2.68	1.34	0.17	0.67	0.17	0.00
Synoviocyte, donor3	11440-118H9	1.56	2.46	2.46	1.56	0.67	0.22	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	32.87	25.01	7.86	11.79	0.36	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	3.96	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	16.44	25.24	2.78	6.25	0.00	0.46	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	22.87	20.57	9.10	4.95	0.50	1.29	0.29	0.93
Tracheal Epithelial Cells, donor2	11369-118A1	11.21	9.66	4.64	3.09	0.39	0.00	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	12.60	10.31	6.30	4.01	0.57	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	8.12	13.90	8.37	2.83	0.37	0.86	0.25	0.37
Urethra, donor2	10319-105A4	10.79	12.59	8.99	5.40	0.00	0.00	3.60	0.00
Urothelial Cells, donor1	11520-119H8	18.06	13.55	7.70	4.52	1.33	0.53	0.00	0.53
Urothelial Cells, donor2	11600-120H7	18.43	16.82	8.41	4.01	0.80	0.40	0.80	0.40
Urothelial Cells, donor3	11681-122H7	23.84	19.02	8.48	4.13	2.06	0.92	0.00	1.15
Urothelial cells, donor0	11216-116B1	19.39	17.61	12.26	5.57	0.67	0.89	0.22	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	5.34	15.13	2.67	2.67	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	7.15	10.01	5.72	7.15	0.00	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	4.11	8.21	6.85	4.11	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	4.82	20.32	11.71	4.13	1.38	2.07	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	8.13	12.20	11.04	3.49	0.58	1.16	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	7.29	12.49	5.21	2.08	1.04	2.08	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	6.42	11.01	2.75	1.84	0.92	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	4.56	14.61	6.39	3.65	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	31.83	16.04	6.29	7.03	1.73	0.25	1.11	0.12
Wilms' tumor cell line:HFWT	10597-108E3	20.24	21.12	14.08	3.52	0.88	0.00	6.16	5.28
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	41.06	43.85	36.59	12.01	7.82	3.35	2.79	3.63
achilles tendon, donor2	10292-104G4	14.47	4.13	10.33	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	86.18	34.93	23.71	31.10	2.55	2.29	2.55	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	108.43	51.31	37.15	34.36	5.11	4.64	1.16	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	63.98	73.84	39.17	25.28	3.92	3.56	1.07	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	48.44	54.42	38.37	21.50	5.17	4.08	3.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	81.23	28.95	29.51	28.67	5.62	1.69	1.12	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	61.33	24.11	22.63	27.70	4.23	2.11	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	38.65	34.84	11.98	15.79	2.99	1.91	4.08	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	36.13	14.54	18.95	16.74	3.08	1.76	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	50.23	16.74	23.68	28.18	5.72	2.04	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	95.52	40.38	36.11	47.37	10.10	2.33	5.44	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	37.35	44.16	29.81	26.13	10.49	1.47	0.55	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	66.31	19.50	31.20	19.50	11.70	0.00	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	59.95	27.42	27.89	22.08	7.44	3.72	1.16	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	66.54	41.42	38.84	35.99	9.58	4.14	0.78	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	76.57	31.56	30.39	41.79	7.31	2.63	0.88	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	68.78	19.52	14.87	22.77	4.18	1.39	1.86	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	23.85	30.02	10.69	17.27	0.82	2.47	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	72.13	8.29	22.71	28.55	7.06	0.31	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	69.98	13.65	20.06	30.72	5.12	1.28	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	64.30	12.74	19.11	26.08	7.28	0.91	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	66.92	16.37	16.61	26.24	5.05	0.96	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	66.82	26.95	18.93	28.07	3.34	2.90	1.11	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	47.36	21.68	31.02	13.34	5.34	2.33	2.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	96.63	11.15	26.01	44.60	0.00	0.00	5.57	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	76.46	13.18	30.13	29.00	9.42	2.64	1.51	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	97.26	28.78	17.45	37.51	5.23	0.87	1.74	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	247.43	5.62	9.37	46.86	7.50	0.00	18.74	0.00
adenocarcinoma cell line:IM95m	10796-110I4	21.67	16.48	9.89	8.01	2.59	1.41	1.65	0.00
adipose tissue, adult, pool1	10010-101C1	6.05	9.31	10.24	4.03	0.93	0.62	0.00	0.16
adipose, donor1	10184-103D4	22.87	51.02	32.84	18.18	5.86	2.93	1.76	0.00
adipose, donor2	10185-103D5	19.46	10.54	13.79	3.65	1.22	1.22	5.27	0.00
adipose, donor3	10186-103D6	25.05	23.69	28.59	5.45	4.63	0.82	1.91	0.00
adipose, donor4	10187-103D7	39.00	124.81	98.81	12.13	6.93	11.27	2.60	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	21.31	14.68	9.47	8.21	2.37	1.42	1.89	0.00
adrenal gland, adult, pool1	10081-102A9	3.64	7.28	7.28	0.00	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	43.36	39.76	38.42	18.94	3.74	2.80	0.53	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	11.08	10.72	10.36	8.22	2.50	1.07	2.86	0.00
amniotic membrane cells, donor1	12235-129G3	4.17	19.01	12.29	0.93	0.23	1.39	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	14.88	26.37	14.88	2.37	1.01	2.37	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	1.77	15.32	8.25	1.18	1.18	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	3.56	5.93	2.37	1.19	0.00	1.19	1.19	0.00
amygdala, adult, donor10252	10151-102I7	8.11	8.72	9.94	1.62	0.20	0.81	0.81	0.20
amygdala, newborn, donor10223	10360-105E9	10.33	9.36	13.56	0.65	0.32	1.61	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	10.70	17.32	9.68	1.40	0.64	1.15	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	49.64	12.35	17.21	18.09	3.09	1.54	1.99	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	17.04	27.39	13.03	6.01	1.00	1.67	6.68	0.00
aorta, adult, pool1	10052-101G7	6.67	3.73	6.47	2.16	0.39	0.78	0.20	0.20
appendix, adult	10189-103D9	24.84	22.90	5.43	8.93	1.55	2.33	1.94	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	10.66	21.67	19.26	6.88	3.10	0.69	1.03	0.00
artery, adult	10190-103E1	0.00	1.36	6.79	0.00	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	18.40	22.31	5.79	8.11	0.43	0.43	0.14	0.29
b cell line:RPMI1788	10427-106D4	44.31	29.89	17.25	17.84	1.64	1.49	0.15	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	8.60	3.88	2.77	2.77	0.55	0.28	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	46.54	21.14	9.13	7.54	1.29	0.99	0.40	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	13.22	17.74	18.08	3.35	2.01	1.51	0.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	19.57	13.98	13.98	13.42	2.24	0.56	2.80	0.00
bladder, adult, pool1	10011-101C2	5.43	6.84	7.82	2.50	0.54	0.33	0.00	0.11
blood, adult, pool1	10053-101G8	13.29	13.29	0.00	4.43	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	12.85	3.43	0.00	1.71	0.00	1.71	0.00	0.00
bone marrow, adult	10192-103E3	32.39	5.40	8.10	8.10	0.00	0.67	0.67	0.67
brain, adult, donor1	10084-102B3	12.30	7.18	9.23	4.10	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	5.35	4.68	6.90	1.89	0.56	0.33	0.00	0.00
brain, fetal, pool1	10085-102B4	8.01	16.03	24.04	2.67	0.00	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	36.67	46.25	26.10	7.27	2.31	3.30	8.26	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	26.34	29.83	14.48	10.36	1.75	1.75	1.37	0.12
breast, adult, donor1	10080-102A8	4.42	8.84	10.10	1.26	0.00	0.00	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	23.88	12.20	17.15	4.45	4.45	2.03	1.27	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	24.74	67.41	29.07	12.99	6.80	4.33	10.20	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	4.37	16.81	19.34	6.22	5.30	0.92	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	23.00	79.65	38.73	9.44	4.84	3.15	5.08	0.97
carcinoid cell line:NCI-H1770	10703-109H1	20.22	27.27	56.89	6.58	10.81	3.29	4.23	0.47
carcinoid cell line:NCI-H727	10735-110B6	16.08	14.66	8.75	3.61	0.88	0.88	0.55	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	6.97	41.83	25.03	2.54	2.22	2.54	4.12	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	31.68	42.85	47.91	12.24	5.32	4.26	2.40	0.00
caudate nucleus - adult, donor10196	10177-103C6	1.15	4.61	11.51	2.30	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	4.85	6.02	8.37	1.51	0.67	0.67	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	3.82	1.53	6.88	2.29	0.76	2.29	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	12.09	6.96	15.38	2.93	1.46	1.10	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	5.83	2.91	23.31	0.00	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	4.27	16.87	41.85	1.49	3.63	4.06	0.00	0.00
cerebellum, adult, pool1	10083-102B2	5.17	4.83	19.32	3.45	0.69	0.69	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	9.96	24.08	32.38	0.83	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	7.06	3.53	7.31	1.51	0.50	0.25	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	10.96	2.19	4.39	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	13.08	89.15	38.97	3.88	4.60	4.17	0.43	2.30
cervical cancer cell line:ME-180	10553-107I4	28.50	104.90	39.11	3.31	3.98	4.97	0.83	4.64
cervix, adult, pool1	10013-101C4	6.93	12.07	12.18	3.04	0.84	1.26	0.10	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	8.78	15.05	13.38	2.09	1.67	1.25	0.14	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	0.00	3.92	3.92	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	11.18	48.84	39.77	4.60	3.98	3.48	0.00	0.37
choriocarcinoma cell line:SCH	10785-110H2	6.78	31.05	11.95	1.36	1.60	1.85	2.09	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	12.10	38.42	14.23	4.74	2.13	2.61	2.61	0.24
chorionic membrane cells, donor1	12238-129G6	2.85	37.61	6.55	0.28	0.00	1.14	0.00	1.99
chorionic membrane cells, donor2	12239-129G7	13.32	21.78	5.27	2.78	0.50	0.80	0.20	0.20
chorionic membrane cells, donor3	12240-129G8	1.65	37.91	11.54	1.65	0.00	1.65	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	26.25	19.19	11.11	14.14	2.02	1.01	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	42.26	18.44	18.83	15.37	3.27	1.73	1.15	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	71.17	17.53	17.11	32.73	5.07	1.27	5.28	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	22.60	32.36	36.47	16.44	5.65	1.80	1.54	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	24.43	33.86	43.05	21.04	6.53	2.18	0.73	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.77	27.69	32.98	16.09	5.70	1.83	0.81	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	25.32	28.86	50.06	22.67	8.83	4.42	3.24	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	56.03	41.44	52.65	33.88	4.69	2.87	1.30	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	30.86	19.43	14.17	11.66	1.37	1.14	1.60	0.00
clear cell carcinoma cell line:TEN	10636-108I6	15.10	14.23	15.44	3.12	3.30	1.04	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	21.23	12.63	12.81	5.31	1.28	1.46	0.73	0.00
colon carcinoma cell line:COLO-320	10420-106C6	14.06	54.35	63.47	8.74	11.02	4.94	0.38	0.00
colon, adult, donor1	10082-102B1	19.04	10.71	16.66	4.76	1.19	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	6.82	7.40	8.23	3.29	1.18	0.47	0.00	0.00
colon, fetal, donor1	10070-101I7	6.18	8.65	6.80	4.33	0.00	0.00	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	430.85	64.17	64.17	96.25	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	29.75	62.89	17.85	9.35	2.97	2.12	1.27	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	47.09	66.41	24.45	21.58	2.87	1.21	1.51	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	49.49	56.40	23.55	24.54	4.65	2.12	0.99	0.14
corpus callosum, adult, pool1	10042-101F6	20.23	7.19	9.29	5.31	1.22	0.44	0.11	0.11
cruciate ligament, donor2	10295-104G7	12.97	8.10	12.16	4.05	2.43	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	12.04	5.62	5.62	3.21	1.61	0.00	0.00	0.00
diencephalon, adult	10193-103E4	4.56	2.88	4.32	1.92	0.48	0.72	0.96	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	76.92	57.86	22.27	25.72	2.30	2.07	0.92	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	18.72	68.73	20.26	6.67	5.64	3.33	0.77	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	18.78	18.29	7.46	3.85	0.96	0.00	0.00	0.24
ductus deferens, adult	10196-103E7	10.96	9.97	6.98	2.49	1.50	1.99	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	20.16	11.52	14.40	1.44	4.32	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	10.30	13.24	16.18	5.15	2.21	1.47	0.74	0.00
dura mater, adult, donor1	10041-101F5	19.41	4.54	6.19	8.09	0.74	0.33	0.00	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	39.08	33.09	15.55	7.11	0.67	1.33	0.89	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	62.19	33.24	28.09	19.49	3.73	1.72	0.43	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	6.17	3.70	6.17	3.08	0.62	0.00	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	5.15	4.54	4.84	1.51	0.91	0.91	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	9.57	8.03	8.95	1.85	2.16	0.62	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	10.51	1.31	6.57	1.31	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	24.47	36.54	19.44	9.39	2.68	3.02	4.36	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	10.87	24.29	17.22	4.71	3.26	1.09	1.27	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	15.28	32.81	11.90	4.50	1.61	1.93	0.32	0.32
epidermoid carcinoma cell line:A431	10426-106D3	46.46	47.24	34.68	10.45	4.22	5.00	2.00	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	30.03	20.68	13.42	9.02	1.98	1.10	0.11	0.00
epididymis, adult	10197-103E8	6.49	11.09	8.16	2.30	0.42	0.84	0.21	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	21.82	8.69	10.47	5.50	0.89	0.89	0.89	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.19	9.83	5.51	5.11	1.18	1.18	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	30.27	77.84	45.61	6.29	9.44	3.15	0.26	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	35.82	80.21	36.02	8.46	6.69	3.64	0.79	0.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	31.03	55.45	36.41	8.74	10.19	3.36	1.12	0.78
esophagus, adult, pool1	10015-101C6	10.94	13.59	11.04	3.19	0.96	0.96	0.32	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	39.20	53.73	15.03	7.14	1.00	2.00	0.50	1.13
eye - muscle inferior rectus, donor1	10272-104E2	7.24	7.24	7.24	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	0.00	0.00	6.31	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	8.93	2.98	2.98	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	12.61	4.59	5.73	2.29	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	11.66	4.37	13.12	7.29	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	6.61	7.63	5.08	2.03	0.76	0.00	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	10.90	9.75	15.52	4.23	3.85	1.03	1.28	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	19.47	13.53	12.11	6.41	4.27	0.95	2.61	0.00
frontal lobe, adult, pool1	10040-101F4	7.60	4.41	8.73	2.06	0.84	0.19	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	27.02	47.74	27.92	8.11	0.60	2.40	1.80	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	10.79	12.16	8.60	4.11	1.10	0.91	0.46	0.00
gall bladder, adult	10198-103E9	19.31	6.04	7.73	5.31	1.21	0.24	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	7.52	15.57	17.72	12.35	0.54	2.68	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	11.95	17.93	13.82	8.96	1.12	1.87	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	21.76	53.44	19.64	3.59	2.32	2.96	1.48	1.69
gastric adenocarcinoma cell line:MKN45	10612-108F9	28.63	43.33	47.19	8.90	7.93	3.29	1.16	1.55
gastric cancer cell line:AZ521	10549-107H9	54.76	50.01	20.49	16.23	3.61	1.48	0.82	0.66
gastric cancer cell line:GSS	10560-108A2	28.37	7.32	19.22	15.56	8.24	2.75	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	12.79	28.10	15.54	0.23	2.06	1.60	0.23	0.00
giant cell carcinoma cell line:LU65	10487-107B1	0.69	10.56	35.23	0.57	6.31	1.26	0.69	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	11.06	9.10	13.44	2.80	1.68	1.26	0.28	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	24.44	40.16	15.46	3.99	3.74	1.25	4.49	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	14.14	6.23	5.17	2.96	0.95	0.32	0.21	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	14.75	5.76	7.58	3.79	0.98	0.28	0.84	0.00
glioblastoma cell line:T98G	10485-107A8	46.80	16.11	14.02	11.48	2.21	1.10	0.77	0.11
glioma cell line:GI-1	10413-106B8	20.21	17.28	14.06	5.56	0.59	1.76	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	10.20	0.73	3.64	1.46	1.46	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	21.97	10.50	10.25	5.86	2.20	0.73	0.98	0.00
globus pallidus, adult, donor10258	10367-105F7	10.95	0.00	4.11	2.74	0.00	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	15.45	6.93	13.86	0.53	0.00	0.53	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	584.87	36.71	39.15	129.70	7.34	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	10.93	0.00	43.71	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	0.00	5.23	47.04	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	18.88	6.40	4.48	4.16	0.32	0.64	1.28	0.00
hIPS +CCl2, biol_rep1	14383-156B9	27.09	69.33	19.28	16.07	6.43	1.84	1.38	0.00
hIPS +CCl2, biol_rep2	14384-156C1	20.12	58.53	10.52	12.80	1.83	2.74	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	23.19	39.29	10.31	17.39	2.58	0.64	0.64	1.29
hIPS, biol_rep1	14380-156B6	21.56	47.43	14.37	8.62	2.87	0.00	4.31	1.44
hIPS, biol_rep2	14381-156B7	34.98	44.58	17.15	13.72	0.69	2.06	1.37	0.69
hIPS, biol_rep3	14382-156B8	5.52	9.93	7.72	9.93	0.00	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	78.73	21.84	14.08	24.71	2.59	1.44	0.57	0.00
heart - mitral valve, adult	10205-103F7	5.08	3.59	9.57	1.49	0.90	0.90	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	4.45	2.35	4.45	2.35	0.26	0.52	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	9.16	11.66	18.32	1.67	5.83	0.83	5.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	9.79	40.61	14.90	1.84	1.63	3.06	0.82	1.43
heart, adult, diseased, donor1	10051-101G6	2.98	3.83	5.54	1.70	1.28	0.85	0.00	0.00
heart, adult, pool1	10016-101C7	5.06	2.30	5.06	2.07	0.00	0.23	0.46	0.00
heart, fetal, pool1	10046-101G1	6.98	9.86	8.21	4.11	0.92	1.03	0.10	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	24.06	2.16	4.01	2.16	0.00	0.00	1.85	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	152.21	13.08	9.51	19.03	0.00	1.19	8.32	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	28.95	19.56	23.87	5.86	3.20	1.10	0.77	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	27.31	18.93	22.21	6.68	3.16	1.70	0.85	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	26.98	19.81	23.04	6.97	3.33	1.62	0.51	0.00
hepatoma cell line:Li-7	10484-107A7	12.01	19.13	7.34	1.11	0.56	0.89	0.11	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	108.64	44.12	26.23	25.13	3.22	3.02	1.41	0.00
hippocampus - adult, donor10196	10169-103B7	5.68	3.79	2.84	4.73	0.00	1.89	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	10.41	13.88	10.82	1.43	1.43	0.82	0.61	0.20
hippocampus, adult, donor10258	10374-105G5	1.49	1.49	1.99	0.50	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	7.40	7.75	11.63	2.47	0.35	1.06	1.06	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	64.70	191.65	92.77	16.48	17.09	7.32	6.71	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	59.69	118.21	58.12	15.32	12.96	3.53	2.55	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	66.77	109.94	65.51	15.49	12.44	4.06	3.81	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	47.93	33.27	21.43	18.04	1.69	1.13	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	32.28	41.31	28.40	11.62	4.13	2.58	1.03	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	40.24	45.93	22.02	10.25	3.42	3.80	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	32.99	27.44	17.52	9.63	1.17	0.88	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	24.34	25.64	22.40	4.09	3.02	0.86	0.65	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	25.02	22.52	20.44	8.76	2.92	0.83	1.67	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	19.65	18.71	11.13	4.26	0.95	0.71	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	26.36	27.16	18.48	7.23	1.61	1.61	0.16	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	25.59	18.85	13.47	8.75	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	56.33	104.84	56.33	12.52	12.68	3.76	2.82	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	37.83	119.88	55.02	12.28	10.81	2.95	2.46	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	55.86	180.66	78.55	19.20	9.60	7.85	6.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	42.76	44.10	28.64	12.79	5.73	2.67	1.53	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	37.94	36.63	29.22	9.16	2.18	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	44.98	48.48	27.49	19.49	2.00	2.50	2.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	11.30	16.96	13.56	2.83	1.70	0.19	1.13	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	11.82	10.00	13.64	2.73	1.36	0.00	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.29	18.48	11.28	5.33	0.94	0.31	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	16.98	19.92	18.94	4.90	0.98	0.82	0.65	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.29	18.58	14.52	4.06	1.16	0.87	1.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	22.12	15.84	18.23	7.47	1.20	0.60	0.90	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	59.67	129.69	68.36	16.63	9.98	5.17	2.40	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	50.78	110.69	46.79	15.12	9.41	2.00	2.85	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	67.78	172.72	62.47	25.32	11.02	2.04	4.08	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	32.04	32.74	26.05	9.15	1.76	0.35	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.92	31.67	28.51	8.24	4.43	1.27	1.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	34.50	31.47	23.30	12.41	4.54	0.91	0.91	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	17.07	16.55	15.51	4.65	1.55	0.52	1.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	13.95	11.95	13.28	4.65	2.66	1.33	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	26.68	19.50	12.83	6.67	1.03	0.77	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	24.29	16.11	12.78	5.62	1.02	0.77	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	24.23	15.90	20.45	3.03	0.76	1.51	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	33.27	13.44	16.13	9.07	2.69	0.34	2.35	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	41.06	130.41	54.58	13.04	6.04	4.35	1.21	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	63.73	140.38	51.70	19.16	6.68	8.91	2.23	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	63.90	132.20	64.88	16.10	11.22	3.90	3.90	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	27.20	48.29	19.25	11.61	1.22	1.22	1.53	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	58.56	123.62	26.03	42.29	13.01	6.51	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	40.71	55.93	29.45	10.92	2.98	3.31	0.99	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	20.25	27.91	13.68	5.47	1.09	0.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	24.97	16.28	13.39	5.43	1.09	1.45	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	19.57	14.95	9.96	6.76	0.71	0.71	1.42	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	17.90	15.51	14.32	4.77	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	27.36	20.72	15.44	5.42	1.22	0.95	0.27	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	24.51	17.78	12.66	7.54	0.54	2.42	1.62	0.00
immature langerhans cells, donor1	11904-125F5	24.94	12.83	3.87	9.69	0.00	1.21	0.00	0.73
immature langerhans cells, donor2	11905-125F6	9.51	7.13	7.92	4.75	1.58	0.79	0.00	1.58
insula, adult, pool1	10039-101F3	9.75	6.06	11.64	3.79	0.66	1.51	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	20.16	25.04	21.13	3.58	2.28	1.63	0.98	0.00
kidney, adult, pool1	10017-101C8	4.61	7.71	6.81	2.00	0.30	1.20	0.30	0.10
kidney, fetal, pool1	10045-101F9	11.46	25.89	18.32	3.61	1.06	1.27	0.00	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	7.39	22.44	12.21	5.40	1.42	1.28	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	4.84	5.11	4.01	2.21	1.24	0.69	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	21.65	17.07	6.79	2.20	0.92	0.92	1.47	0.18
left atrium, adult, donor1	10079-102A7	7.08	6.54	2.18	2.18	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	2.02	1.52	4.55	2.53	0.00	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	36.12	14.50	11.77	10.40	1.92	1.64	3.83	0.00
leiomyoma cell line:10964C	10569-108B2	2.87	0.72	1.44	0.36	0.00	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	4.35	0.54	0.00	1.09	0.00	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	4.61	1.46	1.21	2.19	0.00	0.00	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	17.77	4.18	8.36	0.00	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	14.52	43.45	42.62	9.21	7.67	3.90	1.53	0.00
liposarcoma cell line:KMLS-1	10782-110G8	15.31	3.12	3.59	3.91	0.31	0.47	0.31	0.00
liposarcoma cell line:SW 872	10726-110A6	31.92	7.80	6.46	9.26	1.46	0.49	1.71	0.00
liver, adult, pool1	10018-101C9	3.73	4.21	2.59	1.46	0.65	0.32	0.00	0.00
liver, fetal, pool1	10086-102B5	8.47	15.05	5.64	3.76	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	10.35	6.42	5.10	2.19	0.29	1.02	0.44	0.00
locus coeruleus, adult, donor10252	10165-103B3	12.55	10.89	8.49	2.40	1.85	0.74	0.18	0.00
locus coeruleus, adult, donor10258	10375-105G6	9.87	3.10	7.90	1.69	0.56	0.00	0.56	0.00
locus coeruleus, newborn, donor10223	10362-105F2	6.31	9.25	13.88	2.10	1.68	1.68	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	9.27	8.86	3.60	1.66	0.55	0.69	0.42	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	26.89	13.79	6.20	8.27	0.00	0.00	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	35.06	25.18	4.75	11.60	1.05	1.45	0.79	0.26
lung, adult, pool1	10019-101D1	6.50	9.69	6.14	3.78	0.35	0.83	0.00	0.24
lung, fetal, donor1	10068-101I5	7.71	15.13	9.13	4.85	0.29	2.00	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	15.58	11.46	11.46	7.33	0.00	1.37	0.46	0.00
lymph node, adult, donor1	10077-102A5	5.68	10.89	8.52	2.84	0.47	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	20.38	16.22	4.38	7.67	0.66	0.88	1.32	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	34.56	42.71	9.66	14.79	0.75	1.06	0.60	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	36.53	99.39	54.37	8.49	4.25	7.65	6.80	5.10
mature adipocyte, donor1	12231-129F8	4.88	3.55	3.11	0.89	0.00	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	4.77	7.06	5.40	2.08	0.00	0.42	0.00	0.21
mature adipocyte, donor3	12233-129G1	6.40	3.79	3.56	3.56	0.24	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	7.63	5.00	1.84	3.16	0.53	0.53	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	31.21	142.24	48.84	11.20	8.58	5.72	3.34	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	3.38	7.90	14.66	1.13	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	7.36	12.87	15.08	2.21	1.10	1.47	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	6.04	4.13	5.40	2.54	0.32	0.64	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	6.82	8.53	10.24	3.84	0.00	1.71	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	4.56	5.06	7.43	2.87	0.68	0.34	0.17	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	9.55	12.95	16.34	2.12	1.70	1.27	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	3.85	5.78	1.93	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	43.06	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	7.18	8.97	15.08	1.79	1.79	0.36	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	7.14	4.54	5.19	1.95	0.00	0.65	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	11.15	14.24	9.29	3.10	0.62	0.77	0.31	0.00
medulla oblongata, adult, pool1	10038-101F2	15.51	6.12	10.12	4.49	1.31	0.65	0.08	0.16
medulla oblongata, newborn, donor10223	10361-105F1	9.37	7.29	12.85	3.12	0.35	1.39	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	13.06	54.25	90.56	10.41	11.29	6.20	0.66	0.66
medulloblastoma cell line:ONS-76	10759-110E3	34.97	13.82	11.62	8.44	1.71	0.98	1.59	0.61
melanoma cell line:COLO 679	10514-107E1	48.30	17.97	3.45	5.61	1.15	1.01	0.29	0.00
melanoma cell line:G-361	10465-106H6	22.26	10.04	11.67	3.26	2.17	0.54	0.81	0.81
meningioma cell line:HKBMM	10691-109F7	4.70	17.19	4.16	1.63	0.54	0.90	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	29.96	81.95	52.87	22.91	4.41	2.64	7.05	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	63.25	119.24	112.76	21.00	14.26	8.30	4.93	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	7.52	12.43	5.52	5.37	0.61	0.92	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.09	12.54	4.36	1.82	0.18	0.36	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	4.56	4.56	2.07	2.07	0.00	0.83	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4.35	3.65	2.25	0.98	0.42	0.14	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	4.24	3.27	3.08	0.96	0.00	0.39	0.00	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	2.78	3.47	3.47	1.39	0.00	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	3.78	7.04	3.26	0.34	0.00	0.34	0.00	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	4.83	3.91	4.72	1.61	0.35	0.35	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	11.80	9.28	7.03	3.71	0.80	0.40	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	13.23	5.40	4.86	4.05	0.41	0.54	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	8.25	8.25	3.84	4.69	0.43	0.28	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	6.26	9.22	3.62	0.99	0.33	0.66	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	7.20	7.33	2.35	3.04	0.14	0.83	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	5.24	2.09	1.75	3.14	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	5.92	4.49	3.67	2.86	0.61	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	6.11	7.55	2.16	2.52	0.00	0.36	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.14	3.31	2.38	1.45	0.41	0.10	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.89	2.96	1.60	0.68	0.00	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.85	4.20	5.03	4.20	0.42	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	8.52	7.62	2.24	2.09	0.45	0.15	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	5.95	7.18	3.85	1.84	0.26	0.44	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	4.42	4.42	2.21	1.84	0.37	1.47	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	12.02	5.72	1.72	3.43	0.29	0.00	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.05	8.42	5.47	7.16	2.11	1.26	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.05	6.85	8.68	2.28	0.00	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	5.88	7.16	4.35	1.28	0.00	0.51	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	7.59	7.59	5.24	3.93	0.26	0.26	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.93	8.93	6.78	1.54	0.31	0.92	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.00	9.41	3.06	2.59	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	8.80	9.82	4.74	1.69	0.34	0.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.82	11.00	3.54	0.39	0.39	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	4.17	8.80	2.78	1.85	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	9.23	9.23	6.06	4.04	0.58	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	6.69	8.92	4.24	2.23	0.00	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	6.97	9.61	6.01	1.68	0.00	0.72	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	10.27	9.53	3.67	4.40	0.00	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.40	7.72	4.36	2.69	0.34	1.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	6.55	10.64	3.68	3.28	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	7.30	6.44	5.58	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	2.73	8.20	5.47	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	0.00	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	7.79	8.12	6.50	3.90	0.00	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	5.82	4.36	4.36	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.06	5.33	3.73	3.20	1.60	0.53	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	6.54	2.45	1.64	1.64	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	3.50	5.83	5.05	1.55	0.78	1.17	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	8.39	6.30	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	4.97	4.97	4.97	1.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	4.77	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	5.93	8.30	1.78	1.78	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	4.87	1.22	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	4.43	9.50	5.07	0.63	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	3.45	6.90	4.83	1.03	0.69	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	4.30	2.15	2.15	0.00	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	7.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	6.89	3.44	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	3.67	7.74	2.85	1.63	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	3.97	9.53	3.97	1.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	2.95	5.90	1.77	0.59	0.59	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	1.87	5.30	4.68	0.94	0.31	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	6.68	6.68	1.34	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	1.18	4.73	5.91	3.55	1.18	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	0.00	2.57	12.84	5.14	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	6.88	4.82	4.82	2.07	0.00	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.95	5.94	2.97	2.97	0.00	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	3.36	5.61	4.49	1.12	1.12	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	5.72	7.63	2.54	3.18	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	7.25	4.84	2.42	0.81	0.81	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	8.72	6.54	0.00	0.00	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	6.34	3.80	1.27	1.27	1.27	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	5.46	12.14	4.25	2.43	0.00	0.00	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	0.00	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	7.41	13.18	2.47	2.47	0.00	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	4.37	6.55	4.76	0.60	0.60	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	1.95	4.87	6.17	0.97	0.00	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	5.09	3.06	1.02	0.00	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.99	6.96	3.87	3.09	0.77	1.55	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	8.98	9.69	12.99	4.25	2.83	0.24	2.83	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	55.83	24.56	13.90	11.82	1.85	0.93	3.01	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	12.82	4.27	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	11.10	10.48	4.42	2.77	0.62	0.41	0.00	0.10
mesothelioma cell line:Mero-25	10850-111F4	25.65	23.83	10.67	5.67	1.36	0.68	0.45	0.00
mesothelioma cell line:Mero-41	10851-111F5	22.25	14.42	11.49	10.02	1.96	0.49	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	4.87	7.97	5.54	1.99	0.89	0.44	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	20.76	39.68	13.93	1.58	1.58	2.37	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	12.60	12.26	5.45	3.57	1.70	0.68	0.17	0.00
mesothelioma cell line:Mero-84	10855-111F9	23.51	5.81	4.55	3.03	2.02	0.51	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	28.57	22.57	13.66	6.00	3.31	0.83	0.21	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	25.01	7.95	5.63	3.31	1.66	0.50	0.00	0.17
mesothelioma cell line:NCI-H226	10846-111E9	42.17	8.14	8.14	7.42	1.09	0.00	0.18	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	16.91	8.20	10.76	3.42	1.37	1.20	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	3.82	6.36	8.14	1.53	0.51	0.51	0.00	0.00
mesothelioma cell line:No36	10857-111G2	9.79	15.66	11.09	1.30	0.65	0.98	0.00	0.65
mesothelioma cell line:ONE58	10858-111G3	15.17	10.57	6.23	7.04	0.81	0.27	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	0.77	10.56	7.10	1.92	1.15	0.96	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	2.69	9.65	5.74	3.30	0.37	1.10	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	3.59	8.62	7.72	2.15	0.54	1.08	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	16.32	23.18	18.61	3.26	0.33	0.65	0.65	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	14.41	16.53	13.78	8.69	0.85	1.06	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	46.76	16.13	5.07	8.98	0.92	0.69	2.30	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	29.50	16.17	5.14	10.47	1.33	0.76	1.33	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	55.81	36.03	48.60	25.13	6.84	2.59	1.48	0.37
myeloma cell line:PCM6	10474-106I6	16.41	36.37	9.09	2.37	0.20	0.99	0.59	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	16.23	3.04	5.07	2.54	0.00	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	4.90	9.41	4.51	2.35	0.20	1.37	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	6.91	18.61	11.59	0.56	2.79	1.23	0.00	1.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.66	21.25	12.87	0.66	1.32	1.40	0.22	2.35
nasal epithelial cells, donor2	12227-129F4	7.73	59.61	35.33	2.21	1.10	3.86	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	10.58	46.24	22.09	5.06	2.53	2.07	0.69	0.00
neuroblastoma cell line:NB-1	10539-107G8	30.68	23.57	23.95	15.72	5.05	1.87	0.75	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	9.07	49.98	11.60	5.06	1.27	1.90	0.42	1.05
neuroblastoma cell line:NH-12	10555-107I6	6.34	33.54	11.55	3.17	1.12	1.86	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	1.90	47.68	5.93	1.66	0.24	0.71	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	11.09	62.09	20.91	3.48	2.85	2.53	1.27	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	14.09	24.75	26.57	2.62	3.22	1.81	1.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	13.35	36.87	8.90	4.45	0.64	1.27	4.45	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	23.69	4.26	4.79	3.46	0.00	0.27	1.60	0.53
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	129.55	39.24	40.42	49.21	4.40	2.20	0.34	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	9.61	7.20	8.81	4.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	9.62	11.86	2.89	2.56	0.96	0.00	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	12.09	10.51	2.89	1.31	0.00	0.26	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	8.53	5.53	10.50	2.25	1.03	0.47	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	0.00	6.18	6.18	6.18	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	13.15	14.22	16.64	1.07	1.34	1.07	1.34	0.27
occipital cortex, newborn, donor10223	10355-105E4	8.01	7.28	9.10	1.46	1.09	0.00	1.09	0.00
occipital lobe, adult, donor1	10076-102A4	8.66	6.30	10.50	1.84	0.26	1.31	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	4.72	20.60	20.60	2.15	1.72	0.86	0.00	0.00
occipital pole, adult, pool1	10036-101E9	6.47	4.81	10.56	2.68	1.10	0.79	0.08	0.00
olfactory region, adult	10195-103E6	4.78	5.35	7.45	2.10	0.38	0.38	0.00	0.00
optic nerve, donor1	10277-104E7	16.01	0.00	8.00	8.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	10.25	53.65	21.76	2.28	1.03	2.16	0.11	2.39
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	16.21	45.34	26.65	4.12	2.89	3.16	0.41	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	20.83	45.55	10.33	5.42	1.35	1.86	0.34	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	10.74	30.96	17.44	4.85	1.96	1.73	0.00	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	18.81	7.64	6.17	4.70	0.59	0.59	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	23.36	19.62	6.54	14.02	1.87	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	15.90	37.75	23.11	8.48	1.06	2.12	0.00	0.00
ovary, adult, pool1	10020-101D2	5.33	14.59	10.48	2.27	0.35	0.87	0.09	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	20.17	2.38	4.03	5.13	0.37	0.18	1.65	0.18
pancreas, adult, donor1	10049-101G4	10.35	7.53	14.11	1.88	0.00	1.88	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	12.58	64.29	20.13	6.43	1.96	2.80	3.63	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	11.75	25.04	7.67	3.58	1.19	0.85	1.02	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	30.63	25.00	7.29	7.45	0.83	0.33	0.99	0.00
paracentral gyrus, adult, pool1	10035-101E8	7.60	5.31	10.89	2.20	0.82	0.55	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	1.47	9.54	11.01	3.67	0.00	2.94	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	2.82	7.52	7.52	4.70	0.94	0.94	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	6.56	13.97	11.69	2.00	0.86	2.00	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	8.72	5.64	10.84	2.47	0.62	0.70	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	1.94	25.22	15.52	5.82	0.97	1.94	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	16.82	8.97	11.59	2.24	0.37	0.37	1.12	0.75
parotid gland, adult	10199-103F1	28.37	4.32	7.40	5.55	4.32	0.62	1.23	0.00
penis, adult	10200-103F2	2.15	7.52	6.98	3.22	1.07	1.07	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.00	9.85	1.49	0.00	0.37	0.00	0.00	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	40.94	19.52	9.62	5.83	2.62	1.02	2.33	0.87
pineal gland - adult, donor10196	10179-103C8	3.23	0.65	1.29	0.00	0.65	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	1.78	2.96	8.29	2.37	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	4.39	0.63	2.51	1.88	0.63	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	1.01	5.06	5.06	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	4.17	11.47	16.16	0.00	0.00	1.04	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	2.55	2.55	5.96	1.70	1.70	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	10.86	22.47	8.28	4.19	0.32	1.51	0.75	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	34.56	26.62	6.75	16.82	0.53	0.40	0.53	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	18.68	14.47	11.05	3.89	1.40	0.78	0.62	0.31
pons, adult, pool1	10033-101E6	10.33	6.28	8.86	2.93	1.03	0.52	0.00	0.09
postcentral gyrus, adult, pool1	10032-101E5	8.54	5.93	12.12	3.57	0.78	0.52	0.09	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	372.27	6.27	4.18	54.38	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	0.00	0.00	22.03	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	23.47	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	10.34	17.77	7.87	5.54	1.60	1.31	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	27.59	18.33	12.52	7.26	2.90	1.27	2.18	0.00
prostate, adult, pool1	10022-101D4	6.44	8.16	9.52	2.81	0.73	1.27	0.09	0.09
putamen, adult, donor10196	10176-103C5	4.96	3.78	8.26	1.42	0.47	0.47	0.47	0.00
putamen, adult, donor10252	10152-102I8	7.84	9.80	17.65	1.96	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	5.46	24.04	9.84	2.19	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	3.14	1.45	7.01	1.45	1.45	0.72	0.00	0.24
putamen, newborn, donor10223	10365-105F5	3.00	11.24	18.74	2.25	2.25	1.50	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	43.64	44.51	20.66	11.93	2.62	3.49	6.69	0.58
rectum, fetal, donor1	10067-101I4	31.99	18.08	15.30	27.82	1.39	2.78	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	20.78	6.36	10.81	4.24	1.70	0.64	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	1.24	15.74	9.11	3.31	0.00	0.00	0.41	0.00
retina, adult, pool1	10030-101E3	10.34	5.86	9.84	2.39	0.80	0.70	0.00	0.10
retinoblastoma cell line:Y79	10475-106I7	16.63	47.28	70.15	6.24	5.46	4.68	1.82	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	38.36	13.89	4.18	8.85	1.97	1.23	2.70	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	172.09	47.52	32.34	36.84	3.37	2.81	9.00	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	13.64	0.00	1.52	3.79	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	4.05	7.77	8.74	0.97	0.65	0.81	0.16	0.00
salivary acinar cells, donor2	11772-123I8	2.89	9.64	10.60	0.69	0.96	1.24	0.00	0.28
salivary acinar cells, donor3	11773-123I9	11.92	14.57	7.94	2.65	0.66	0.66	0.66	0.66
salivary gland, adult, pool1	10093-102C3	9.72	3.43	4.58	1.14	0.57	0.00	0.00	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	5.31	10.29	3.96	1.77	0.93	0.25	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	2.47	10.81	3.53	3.17	0.59	0.35	0.12	0.00
seminal vesicle, adult	10201-103F3	7.94	8.47	9.52	0.53	1.59	0.53	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	17.00	14.58	13.12	5.34	1.21	2.43	0.49	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	10.57	5.54	2.77	2.52	0.75	0.00	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	33.12	12.04	14.05	12.04	0.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	22.03	30.36	15.85	3.63	0.94	2.28	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	59.91	45.65	23.98	8.51	4.75	2.21	0.99	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	42.32	5.42	5.03	13.42	2.71	0.52	0.65	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	1.42	0.00	2.13	0.00	0.71	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	1.56	5.88	6.60	0.72	0.12	0.72	0.24	0.00
skeletal muscle, fetal, donor1	10066-101I3	12.06	7.04	12.06	5.03	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	6.79	13.57	13.57	0.00	0.00	0.00	0.00	13.57
skin, fetal, donor1	10065-101I2	11.99	20.20	15.15	10.73	1.26	0.00	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	36.35	44.36	15.34	11.67	2.33	3.34	1.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	25.85	58.31	49.49	9.46	2.21	6.30	1.58	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	14.84	37.20	41.63	9.64	8.87	4.05	0.39	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	35.44	98.73	15.99	8.41	1.81	3.46	1.15	1.65
small cell lung carcinoma cell line:NCI-H82	10842-111E5	15.12	29.60	68.20	8.20	21.39	3.06	2.09	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	23.10	43.80	21.14	11.77	3.70	3.27	1.31	1.09
small intestine, adult, pool1	10024-101D6	9.56	8.24	10.27	5.02	1.07	0.84	0.48	0.00
small intestine, fetal, donor1	10064-101I1	14.50	10.32	13.51	7.86	1.23	0.74	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	13.34	52.83	20.00	5.13	1.54	2.05	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	3.62	3.62	7.24	3.10	1.03	0.52	0.52	0.26
somatostatinoma cell line:QGP-1	10781-110G7	9.65	18.49	6.97	2.41	0.80	0.54	1.34	0.80
spinal cord - adult, donor10196	10181-103D1	14.22	4.59	7.80	2.75	0.46	0.00	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	16.95	7.10	10.25	1.58	1.97	0.00	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	0.69	4.15	2.08	0.69	0.69	0.00	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	20.73	9.76	14.64	6.10	1.22	1.22	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	12.40	10.56	11.94	2.76	0.46	0.92	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	30.47	5.97	2.69	4.48	0.60	0.30	0.90	0.00
spleen, adult, pool1	10025-101D7	14.65	16.52	10.02	8.81	0.88	0.55	0.44	0.00
spleen, fetal, pool1	10044-101F8	23.68	24.31	14.38	10.17	1.19	1.19	0.08	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	31.47	21.43	11.70	12.94	1.24	1.14	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	19.56	25.06	12.91	4.18	2.28	0.76	3.04	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	12.93	88.06	29.35	2.80	3.15	4.54	0.35	2.45
squamous cell carcinoma cell line:T3M-5	10616-108G4	18.37	14.86	6.65	0.78	1.56	0.39	2.35	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	25.21	36.81	33.09	6.19	3.83	2.25	0.79	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	11.44	11.01	10.17	5.93	1.69	1.27	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	10.58	8.88	6.77	5.50	2.12	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	30.97	6.41	6.41	7.48	0.00	1.07	6.41	0.00
submaxillary gland, adult	10202-103F4	25.07	8.55	6.84	5.13	1.71	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	17.86	10.18	6.85	2.70	0.62	1.04	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	3.10	0.52	1.55	0.52	0.00	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	14.84	8.48	12.01	2.12	2.12	0.71	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	17.19	22.47	22.24	12.38	4.59	0.92	1.38	0.00
temporal lobe, adult, pool1	10031-101E4	9.16	5.59	10.09	2.80	0.76	0.93	0.08	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	2.14	20.66	17.09	4.27	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	2.64	15.38	16.70	2.20	0.00	1.32	0.00	0.00
tenocyte, donor1	11763-123H8	13.96	6.98	4.19	2.79	0.70	0.35	0.35	0.00
tenocyte, donor2	11765-123I1	5.34	8.01	4.58	1.53	0.00	0.38	0.00	0.38
tenocyte, donor3	11768-123I4	8.90	5.56	4.08	3.71	0.00	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	88.72	109.79	21.08	21.25	3.74	2.72	7.31	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	24.97	7.40	18.19	6.32	3.24	0.62	1.23	0.31
teratocarcinoma cell line:PA-1	10807-111A6	30.38	31.15	14.57	7.28	2.79	1.86	2.63	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	82.26	74.65	12.57	13.96	1.78	1.27	8.63	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	47.27	85.85	31.77	13.61	5.67	1.89	3.78	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	23.12	39.92	8.29	4.69	1.31	1.31	0.00	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	58.63	127.68	10.75	12.38	3.26	1.63	5.86	0.00
testis, adult, pool1	10026-101D8	7.73	8.27	8.38	3.65	0.75	1.07	0.11	0.00
testis, adult, pool2	10096-102C6	9.92	12.63	10.37	9.02	2.71	2.71	0.45	0.00
thalamus - adult, donor10196	10168-103B6	6.62	1.10	5.52	2.21	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	14.22	11.72	9.85	2.34	1.25	1.09	0.31	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	3.08	7.70	4.62	0.00	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	4.94	3.46	8.23	1.48	0.66	0.33	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	8.63	5.75	9.21	1.15	1.15	0.58	0.58	0.00
throat, adult	10209-103G2	10.24	10.99	8.24	4.99	0.75	1.25	0.50	0.25
throat, fetal, donor1	10061-101H7	14.63	10.97	11.58	4.88	0.91	1.22	0.91	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	18.08	36.37	16.49	6.16	4.77	1.39	1.59	0.20
thymus, adult, pool1	10027-101D9	21.87	68.30	27.84	18.09	1.49	3.68	0.10	0.30
thymus, fetal, pool1	10043-101F7	20.47	54.34	17.56	11.53	1.04	2.39	0.00	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	19.15	10.64	8.91	4.65	1.20	0.66	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	14.25	19.56	18.72	5.59	4.05	1.12	1.96	0.42
thyroid, adult, pool1	10028-101E1	3.92	14.65	11.66	1.87	0.84	0.93	0.00	0.09
thyroid, fetal, donor1	10060-101H6	10.28	10.02	10.55	3.43	1.58	1.58	1.32	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	6.16	18.48	15.40	6.16	0.00	6.16	0.00
tongue, adult	10203-103F5	6.74	8.84	12.79	1.63	2.09	1.16	0.00	0.70
tongue, fetal, donor1	10059-101H5	8.28	11.43	12.22	2.76	1.18	0.00	0.39	0.00
tonsil, adult, pool1	10047-101G2	27.75	29.95	16.33	9.02	1.10	1.00	0.20	0.50
trachea, adult, pool1	10029-101E2	11.04	12.19	8.92	3.52	1.23	1.06	0.16	0.08
trachea, fetal, donor1	10058-101H4	10.00	13.46	9.23	5.00	0.77	0.77	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	15.59	4.96	2.48	1.77	0.35	0.35	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	67.68	58.66	20.77	18.14	1.72	2.53	1.32	1.01
transitional-cell carcinoma cell line:JMSU1	10492-107B6	17.39	53.43	71.14	6.89	10.34	3.60	1.25	0.16
tridermal teratoma cell line:HGRT	10694-109G1	24.73	7.61	3.81	5.71	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	7.45	5.67	2.96	1.02	0.68	0.34	0.17	0.00
umbilical cord, fetal, donor1	10057-101H3	8.35	20.87	10.43	8.35	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	3.75	8.02	8.36	2.73	0.68	0.68	0.00	0.00
uterus, fetal, donor1	10055-101H1	14.85	16.89	10.75	5.63	0.00	1.02	2.56	0.00
vagina, adult	10204-103F6	1.94	16.80	7.11	0.00	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	11.62	14.25	7.45	8.33	1.32	1.10	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	17.36	13.89	7.48	7.74	0.80	0.27	0.27	0.00